BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011;13:317-23. [PMID: 21336307 DOI: 10.1038/ncb2173] [Cited by in Crossref: 510] [Cited by in F6Publishing: 484] [Article Influence: 46.4] [Reference Citation Analysis]
Number Citing Articles
1 Tamura M, Sasaki Y, Koyama R, Takeda K, Idogawa M, Tokino T. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness. Oncogene 2014;33:4837-46. [PMID: 24186199 DOI: 10.1038/onc.2013.427] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
2 Wang Z, Murakami R, Yuki K, Yoshida Y, Noda M. Bioinformatic Studies to Predict MicroRNAs with the Potential of Uncoupling RECK Expression from Epithelial-Mesenchymal Transition in Cancer Cells. Cancer Inform 2016;15:91-102. [PMID: 27226706 DOI: 10.4137/CIN.S34141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Sandhu GK, Milevskiy MJG, Wilson W, Shewan AM, Brown MA. Non-coding RNAs in Mammary Gland Development and Disease. Adv Exp Med Biol 2016;886:121-53. [PMID: 26659490 DOI: 10.1007/978-94-017-7417-8_7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
4 Pavlopoulou A, Oktay Y, Vougas K, Louka M, Vorgias CE, Georgakilas AG. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells. Cancer Letters 2016;380:485-93. [DOI: 10.1016/j.canlet.2016.07.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
5 Pasi CE, Pelicci PG. Inhibition of epithelial-to-mesenchimal transition: a novel tumor suppressor function of p53? Cell Cycle 2011;10:2616-7. [PMID: 21836395 DOI: 10.4161/cc.10.16.16543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, Liu Y, He Y, Park EY, Zhang H. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J Biol Chem. 2012;287:465-473. [PMID: 22074923 DOI: 10.1074/jbc.m111.280768] [Cited by in Crossref: 104] [Cited by in F6Publishing: 65] [Article Influence: 9.5] [Reference Citation Analysis]
7 Gouda MM, Shaikh SB, Bhandary YP. Inflammatory and Fibrinolytic System in Acute Respiratory Distress Syndrome. Lung 2018;196:609-16. [PMID: 30121847 DOI: 10.1007/s00408-018-0150-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
8 Shakib H, Rajabi S, Dehghan MH, Mashayekhi FJ, Safari-Alighiarloo N, Hedayati M. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review. Endocrine 2019;66:435-55. [PMID: 31378850 DOI: 10.1007/s12020-019-02030-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
9 Méndez-Vidal C, Gámez-Del Estal MM, Moreno-Mateos MA, Espina-Zambrano AG, Torres B, Pintor-Toro JA. PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis. Cell Death Dis 2013;4:e530. [PMID: 23470537 DOI: 10.1038/cddis.2013.48] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19:1438-1449. [PMID: 24202396 DOI: 10.1038/nm.3336] [Cited by in Crossref: 743] [Cited by in F6Publishing: 709] [Article Influence: 82.6] [Reference Citation Analysis]
11 Chang CC, Wu MJ, Yang JY, Camarillo IG, Chang CJ. Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression. Cancer Res 2015;75:2375-86. [PMID: 25840984 DOI: 10.1158/0008-5472.CAN-14-3076] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 10.3] [Reference Citation Analysis]
12 Jafarnejad SM, Li G. Regulation of p53 by ING family members in suppression of tumor initiation and progression. Cancer Metastasis Rev 2012;31:55-73. [PMID: 22095030 DOI: 10.1007/s10555-011-9329-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
13 Kim Y, Park JB, Fukuda J, Watanabe M, Chun YS. The Effect of Neddylation Blockade on Slug-Dependent Cancer Cell Migration Is Regulated by p53 Mutation Status. Cancers (Basel) 2021;13:531. [PMID: 33573293 DOI: 10.3390/cancers13030531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cho JH, Patel B, Bonala S, Mansouri H, Manne S, Vadrevu SK, Ghouse S, Kung CP, Murphy ME, Astrinidis A, Henske EP, Kwiatkowski DJ, Markiewski MM, Karbowniczek M. The Codon 72 TP53 Polymorphism Contributes to TSC Tumorigenesis through the Notch-Nodal Axis. Mol Cancer Res 2019;17:1639-51. [PMID: 31088907 DOI: 10.1158/1541-7786.MCR-18-1292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Chandrakesan P, Weygant N, May R, Qu D, Chinthalapally HR, Sureban SM, Ali N, Lightfoot SA, Umar S, Houchen CW. DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition. Oncotarget. 2014;5:9269-9280. [PMID: 25211188 DOI: 10.18632/oncotarget.2393] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
16 Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors. J Exp Clin Cancer Res 2018;37:314. [PMID: 30547810 DOI: 10.1186/s13046-018-0988-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
17 He P, Qiu K, Jia Y. Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells. Sci Rep 2018;8:14323. [PMID: 30254295 DOI: 10.1038/s41598-018-32737-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
18 Rogac M, Kitanovski L, Writzl K. Co-occurrence of rhabdomyosarcoma and Mowat-Wilson syndrome: is there a connection? Clin Dysmorphol 2017;26:185-6. [PMID: 28230647 DOI: 10.1097/MCD.0000000000000174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhang Y, Yan W, Chen X. Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions. J Biol Chem 2011;286:16218-28. [PMID: 21454711 DOI: 10.1074/jbc.M110.214585] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
20 Kooistra SM, Nørgaard LC, Lees MJ, Steinhauer C, Johansen JV, Helin K. A screen identifies the oncogenic micro-RNA miR-378a-5p as a negative regulator of oncogene-induced senescence. PLoS One 2014;9:e91034. [PMID: 24651706 DOI: 10.1371/journal.pone.0091034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
21 Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem Cells 2012;30:2366-77. [PMID: 22961641 DOI: 10.1002/stem.1219] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 8.2] [Reference Citation Analysis]
22 Saito S, Tampe B, Müller GA, Zeisberg M. Primary cilia modulate balance of canonical and non-canonical Wnt signaling responses in the injured kidney. Fibrogenesis Tissue Repair 2015;8:6. [PMID: 25901180 DOI: 10.1186/s13069-015-0024-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
23 Carta A, Chetcuti R, Ayers D. An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance. Genet Res Int 2014;2014:743050. [PMID: 25548681 DOI: 10.1155/2014/743050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
24 Knight JF, Lesurf R, Zhao H, Pinnaduwage D, Davis RR, Saleh SM, Zuo D, Naujokas MA, Chughtai N, Herschkowitz JI, Prat A, Mulligan AM, Muller WJ, Cardiff RD, Gregg JP, Andrulis IL, Hallett MT, Park M. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proc Natl Acad Sci U S A 2013;110:E1301-10. [PMID: 23509284 DOI: 10.1073/pnas.1210353110] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
25 Ding XM. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT). Chin J Cancer. 2014;33:140-147. [PMID: 24016392 DOI: 10.5732/cjc.013.10094] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 7.0] [Reference Citation Analysis]
26 Olivos DJ, Mayo LD. Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness. Int J Mol Sci 2016;17:E1982. [PMID: 27898034 DOI: 10.3390/ijms17121982] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
27 Zaravinos A. The Regulatory Role of MicroRNAs in EMT and Cancer. J Oncol. 2015;2015:865816. [PMID: 25883654 DOI: 10.1155/2015/865816] [Cited by in Crossref: 160] [Cited by in F6Publishing: 163] [Article Influence: 22.9] [Reference Citation Analysis]
28 Chao CH, Chang CC, Wu MJ, Ko HW, Wang D, Hung MC, Yang JY, Chang CJ. MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis. J Clin Invest 2014;124:3093-106. [PMID: 24911147 DOI: 10.1172/JCI73351] [Cited by in Crossref: 80] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
29 Yang Y, Tarapore RS, Jarmel MH, Tetreault MP, Katz JP. p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation. Cell Cycle 2012;11:4033-9. [PMID: 22990386 DOI: 10.4161/cc.22265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
30 Lin Y, Mallen-St Clair J, Luo J, Sharma S, Dubinett S, St John M. p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol 2015;51:921-8. [PMID: 26306422 DOI: 10.1016/j.oraloncology.2015.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhang J, Qian L, Wu J, Lu D, Yuan H, Li W, Ying X, Hu S. Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells. Biochemical and Biophysical Research Communications 2019;513:472-8. [DOI: 10.1016/j.bbrc.2019.03.207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
32 Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14:359-370. [PMID: 24739573 DOI: 10.1038/nrc3711] [Cited by in Crossref: 744] [Cited by in F6Publishing: 713] [Article Influence: 93.0] [Reference Citation Analysis]
33 Karimi Dermani F, Amini R, Saidijam M, Najafi R. miR‐200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial‐mesenchymal transition in colorectal cancer. J Cell Biochem 2018;119:6288-95. [DOI: 10.1002/jcb.26880] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
34 Bi Y, Shen W, Min M, Liu Y. MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma. Int J Mol Med 2017;39:900-6. [PMID: 28259961 DOI: 10.3892/ijmm.2017.2894] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
35 Bitting RL, Schaeffer D, Somarelli JA, Garcia-Blanco MA, Armstrong AJ. The role of epithelial plasticity in prostate cancer dissemination and treatment resistance. Cancer Metastasis Rev 2014;33:441-68. [PMID: 24414193 DOI: 10.1007/s10555-013-9483-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
36 Belgardt BF, Ahmed K, Spranger M, Latreille M, Denzler R, Kondratiuk N, von Meyenn F, Villena FN, Herrmanns K, Bosco D, Kerr-Conte J, Pattou F, Rülicke T, Stoffel M. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nat Med 2015;21:619-27. [PMID: 25985365 DOI: 10.1038/nm.3862] [Cited by in Crossref: 155] [Cited by in F6Publishing: 151] [Article Influence: 22.1] [Reference Citation Analysis]
37 Yeo CD, Kang N, Choi SY, Kim BN, Park CK, Kim JW, Kim YK, Kim SJ. The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation. Korean J Intern Med. 2017;32:589-599. [PMID: 28704917 DOI: 10.3904/kjim.2016.302] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
38 Kahlert UD, Nikkhah G, Maciaczyk J. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett 2013;331:131-8. [PMID: 23268331 DOI: 10.1016/j.canlet.2012.12.010] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 12.6] [Reference Citation Analysis]
39 Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-355. [PMID: 22337054 DOI: 10.1038/nature1088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Tordonato C, Di Fiore PP, Nicassio F. The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors. Front Genet. 2015;6:72. [PMID: 25774169 DOI: 10.3389/fgene.2015.00072] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
41 Bai X, Li YY, Zhang HY, Wang F, He HL, Yao JC, Liu L, Li SS. Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Onco Targets Ther 2017;10:2837-47. [PMID: 28652766 DOI: 10.2147/OTT.S134813] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
42 Prabhu VV, Allen JE, Hong B, Zhang S, Cheng H, El-Deiry WS. Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opin Ther Targets 2012;16:1161-74. [PMID: 22998602 DOI: 10.1517/14728222.2012.726985] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
43 Ansieau S. EMT in breast cancer stem cell generation. Cancer Lett 2013;338:63-8. [PMID: 22634497 DOI: 10.1016/j.canlet.2012.05.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
44 Sowamber R, Chehade R, Bitar M, Dodds LV, Milea A, Slomovitz B, Shaw PA, George SHL. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma. EBioMedicine 2019;44:261-74. [PMID: 31078521 DOI: 10.1016/j.ebiom.2019.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Díaz VM, Viñas-Castells R, García de Herreros A. Regulation of the protein stability of EMT transcription factors. Cell Adh Migr 2014;8:418-28. [PMID: 25482633 DOI: 10.4161/19336918.2014.969998] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
46 Diepenbruck M, Christofori G. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7-13. [PMID: 27371787 DOI: 10.1016/j.ceb.2016.06.002] [Cited by in Crossref: 246] [Cited by in F6Publishing: 247] [Article Influence: 41.0] [Reference Citation Analysis]
47 Gonzales KA, Liang H, Lim YS, Chan YS, Yeo JC, Tan CP, Gao B, Le B, Tan ZY, Low KY, Liou YC, Bard F, Ng HH. Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways. Cell 2015;162:564-79. [PMID: 26232226 DOI: 10.1016/j.cell.2015.07.001] [Cited by in Crossref: 133] [Cited by in F6Publishing: 111] [Article Influence: 19.0] [Reference Citation Analysis]
48 Kato M, Natarajan R. MicroRNA circuits in transforming growth factor-β actions and diabetic nephropathy. Semin Nephrol 2012;32:253-60. [PMID: 22835456 DOI: 10.1016/j.semnephrol.2012.04.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
49 Li X, Pei D, Zheng H. Transitions between epithelial and mesenchymal states during cell fate conversions. Protein Cell 2014;5:580-91. [PMID: 24805308 DOI: 10.1007/s13238-014-0064-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
50 Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA, Ling TY, Yu SL, Yuan SS, Chen YJ, Lin CY, Pan SH, Chou HY, Chen YJ, Chang GC, Chu WC, Lee YM, Lee JY, Lee PJ, Li KC, Chen HW, Yang PC. Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling. Nat Commun 2014;5:3472. [PMID: 24668028 DOI: 10.1038/ncomms4472] [Cited by in Crossref: 192] [Cited by in F6Publishing: 197] [Article Influence: 24.0] [Reference Citation Analysis]
51 Izawa G, Kobayashi W, Haraguchi M, Sudo A, Ozawa M. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition. Int J Mol Med 2015;36:166-72. [PMID: 25998899 DOI: 10.3892/ijmm.2015.2215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX. Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition. Onco Targets Ther 2017;10:3435-51. [PMID: 28744148 DOI: 10.2147/OTT.S139546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
53 Yasui K, Shimamura M, Mitsutake N, Nagayama Y. SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells. Thyroid. 2013;23:989-996. [PMID: 23432420 DOI: 10.1089/thy.2012.0319] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
54 Wang HY, Zhang XP, Wang W. Regulation of epithelial-to-mesenchymal transition in hypoxia by the HIF-1α network. FEBS Lett 2021. [PMID: 34905218 DOI: 10.1002/1873-3468.14258] [Reference Citation Analysis]
55 Zhao K, Wang D, Zhao X, Wang C, Gao Y, Liu K, Wang F, Wu X, Wang X, Sun L, Zang J, Mei Y. WDR63 inhibits Arp2/3-dependent actin polymerization and mediates the function of p53 in suppressing metastasis. EMBO Rep 2020;21:e49269. [PMID: 32128961 DOI: 10.15252/embr.201949269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Broster SA, Kyprianou N. Epithelial–mesenchymal transition in prostatic disease. Future Oncology 2015;11:3197-206. [DOI: 10.2217/fon.15.253] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
57 Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62:1315-1326. [PMID: 22735571 DOI: 10.1136/gutjnl-2011-301846] [Cited by in Crossref: 352] [Cited by in F6Publishing: 361] [Article Influence: 35.2] [Reference Citation Analysis]
58 Voutsadakis IA. Mutations of p53 associated with pancreatic cancer and therapeutic implications. Ann Hepatobiliary Pancreat Surg 2021;25:315-27. [PMID: 34402431 DOI: 10.14701/ahbps.2021.25.3.315] [Reference Citation Analysis]
59 Avery-Kiejda KA, Morten B, Wong-Brown MW, Mathe A, Scott RJ. The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome. Carcinogenesis. 2014;35:586-596. [PMID: 24336193 DOI: 10.1093/carcin/bgt411] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
60 Long H, Wang Z, Chen J, Xiang T, Li Q, Diao X, Zhu B. microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu). Oncotarget 2015;6:38705-18. [PMID: 26462018 DOI: 10.18632/oncotarget.5478] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
61 Wu MJ, Kim MR, Chang CJ. Regulation of microRNA-200c in cancer stem cells. Oncoscience 2015;2:745-6. [PMID: 26501077 DOI: 10.18632/oncoscience.204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
62 Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg 2014;259:346-54. [PMID: 24135722 DOI: 10.1097/SLA.0000000000000223] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
63 Cho SY, Park C, Na D, Han JY, Lee J, Park OK, Zhang C, Sung CO, Moon HE, Kim Y, Kim JH, Kim JJ, Khang SK, Nam DH, Choi JW, Suh YL, Kim DG, Park SH, Youn H, Yun K, Kim JI, Lee C, Paek SH, Park H. High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients. Exp Mol Med 2017;49:e317. [PMID: 28408749 DOI: 10.1038/emm.2017.9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
64 Liu W, Qin H, Pan Y, Luo F, Zhang Z. Low concentrations of perfluorooctane sulfonate repress osteogenic and enhance adipogenic differentiation of human mesenchymal stem cells. Toxicology and Applied Pharmacology 2019;367:82-91. [DOI: 10.1016/j.taap.2019.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
65 Liu Z, Liu H, Desai S, Schmitt DC, Zhou M, Khong HT, Klos KS, McClellan S, Fodstad O, Tan M. miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. J Biol Chem 2013;288:4334-45. [PMID: 23255607 DOI: 10.1074/jbc.M112.419168] [Cited by in Crossref: 42] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
66 Li XL, Hara T, Choi Y, Subramanian M, Francis P, Bilke S, Walker RL, Pineda M, Zhu Y, Yang Y, Luo J, Wakefield LM, Brabletz T, Park BH, Sharma S, Chowdhury D, Meltzer PS, Lal A. A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol 2014;34:533-50. [PMID: 24277930 DOI: 10.1128/MCB.01043-13] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
67 Langer EM, Kendsersky ND, Daniel CJ, Kuziel GM, Pelz C, Murphy KM, Capecchi MR, Sears RC. ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells. Oncogene 2018;37:1005-19. [PMID: 29084210 DOI: 10.1038/onc.2017.356] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
68 Zeng Q, Zhang Y, Zhang W, Guo Q. Baicalein suppresses the proliferation and invasiveness of colorectal cancer cells by inhibiting Snail‑induced epithelial‑mesenchymal transition. Mol Med Rep 2020;21:2544-52. [PMID: 32323825 DOI: 10.3892/mmr.2020.11051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
69 Savagner P. Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity. Curr Top Dev Biol 2015;112:273-300. [PMID: 25733143 DOI: 10.1016/bs.ctdb.2014.11.021] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 12.7] [Reference Citation Analysis]
70 Yang T, Cheng J, Yang Y, Qi W, Zhao Y, Long H, Xie R, Zhu B. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53: S100B Regulates Stemness. Stem Cells 2017;35:325-36. [DOI: 10.1002/stem.2472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
71 Li Z, Wang L, Xu J, Yang Z. MiRNA expression profile and miRNA-mRNA integrated analysis (MMIA) during podocyte differentiation. Mol Genet Genomics 2015;290:863-75. [PMID: 25433550 DOI: 10.1007/s00438-014-0960-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
72 Gundamaraju R, Lu W, Azimi I, Eri R, Sohal SS. Endogenous Anti-Cancer Candidates in GPCR, ER Stress, and EMT. Biomedicines 2020;8:E402. [PMID: 33050301 DOI: 10.3390/biomedicines8100402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
73 Nantajit D, Lin D, Li JJ. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol 2015;141:1697-713. [PMID: 25270087 DOI: 10.1007/s00432-014-1840-y] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 8.4] [Reference Citation Analysis]
74 Moustakas A, Heldin P. TGFβ and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta. 2014;1840:2621-2634. [PMID: 24561266 DOI: 10.1016/j.bbagen.2014.02.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 11.1] [Reference Citation Analysis]
75 Weygant N, Ge Y, Qu D, Kaddis JS, Berry WL, May R, Chandrakesan P, Bannerman-Menson E, Vega KJ, Tomasek JJ, Bronze MS, An G, Houchen CW. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase. Cancer Res 2016;76:4090-9. [PMID: 27287716 DOI: 10.1158/0008-5472.CAN-16-0029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
76 Tamura M, Sasaki Y, Kobashi K, Takeda K, Nakagaki T, Idogawa M, Tokino T. CRKL oncogene is downregulated by p53 through miR-200s. Cancer Sci 2015;106:1033-40. [PMID: 26079153 DOI: 10.1111/cas.12713] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
77 Lin J, Wang C, Liu J, Dahlgren RA, Ai W, Zeng A, Wang X, Wang H. Up-stream mechanisms for up-regulation of miR-125b from triclosan exposure to zebrafish (Danio rerio). Aquatic Toxicology 2017;193:256-67. [DOI: 10.1016/j.aquatox.2017.10.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
78 Batista L, Bourachot B, Mateescu B, Reyal F, Mechta-Grigoriou F. Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through. Nat Commun 2016;7:8959. [PMID: 26725650 DOI: 10.1038/ncomms9959] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
79 Wen FC, Chang TW, Tseng YL, Lee JC, Chang MC. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription. Carcinogenesis 2014;35:1481-90. [PMID: 24403312 DOI: 10.1093/carcin/bgu009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
80 Avtanski DB, Nagalingam A, Tomaszewski JE, Risbood P, Difillippantonio MJ, Saxena NK, Malhotra SV, Sharma D. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis. Mol Oncol. 2016;10:1118-1132. [PMID: 27259808 DOI: 10.1016/j.molonc.2016.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
81 Giacomelli C, Daniele S, Natali L, Iofrida C, Flamini G, Braca A, Trincavelli ML, Martini C. Carnosol controls the human glioblastoma stemness features through the epithelial-mesenchymal transition modulation and the induction of cancer stem cell apoptosis. Sci Rep 2017;7:15174. [PMID: 29123181 DOI: 10.1038/s41598-017-15360-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
82 Hünten S, Hermeking H. p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3. Oncotarget 2015;6:15842-56. [PMID: 26158294 DOI: 10.18632/oncotarget.4683] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
83 Roy SS, Gonugunta VK, Bandyopadhyay A, Rao MK, Goodall GJ, Sun LZ, Tekmal RR, Vadlamudi RK. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene 2014;33:3707-16. [PMID: 23975430 DOI: 10.1038/onc.2013.332] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.7] [Reference Citation Analysis]
84 Yu F, Bracken CP, Pillman KA, Lawrence DM, Goodall GJ, Callen DF, Neilsen PM. p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA. PLoS One 2015;10:e0129190. [PMID: 26061048 DOI: 10.1371/journal.pone.0129190] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
85 Ecoy GAU, Chamni S, Suwanborirux K, Chanvorachote P, Chaotham C. Jorunnamycin A from Xestospongia sp. Suppresses Epithelial to Mesenchymal Transition and Sensitizes Anoikis in Human Lung Cancer Cells. J Nat Prod 2019;82:1861-73. [PMID: 31260310 DOI: 10.1021/acs.jnatprod.9b00102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
86 Ju Q, Zhao L, Gao J, Zhou L, Xu Y, Sun Y, Zhao X. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis. Chin J Cancer Res 2019;31:533-46. [PMID: 31354222 DOI: 10.21147/j.issn.1000-9604.2019.03.15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
87 He S, Carman CV, Lee JH, Lan B, Koehler S, Atia L, Park CY, Kim JH, Mitchel JA, Park JA, Butler JP, Lu Q, Fredberg JJ. The tumor suppressor p53 can promote collective cellular migration. PLoS One 2019;14:e0202065. [PMID: 30707705 DOI: 10.1371/journal.pone.0202065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
88 Kahlert UD, Suwala AK, Raabe EH, Siebzehnrubl FA, Suarez MJ, Orr BA, Bar EE, Maciaczyk J, Eberhart CG. ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. Brain Pathol 2015;25:724-32. [PMID: 25521330 DOI: 10.1111/bpa.12240] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
89 Alamudi SH, Chang Y. Advances in the design of cell-permeable fluorescent probes for applications in live cell imaging. Chem Commun 2018;54:13641-53. [DOI: 10.1039/c8cc08107g] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 7.8] [Reference Citation Analysis]
90 Xu W, Li C, Ma B, Lu Z, Wang Y, Jiang H, Luo Y, Yang Y, Wang X, Liao T, Ji Q, Wang Y, Wei W. Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer. Front Oncol 2021;11:641851. [PMID: 33996555 DOI: 10.3389/fonc.2021.641851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Wu MJ, Kim MR, Chen YS, Yang JY, Chang CJ. Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway. Oncogene 2017;36:3193-206. [PMID: 28218902 DOI: 10.1038/onc.2016.467] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
92 Ebata T, Hirata H, Kawauchi K. Functions of the Tumor Suppressors p53 and Rb in Actin Cytoskeleton Remodeling. Biomed Res Int 2016;2016:9231057. [PMID: 28078303 DOI: 10.1155/2016/9231057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
93 Novikov NM, Zolotaryova SY, Gautreau AM, Denisov EV. Mutational drivers of cancer cell migration and invasion. Br J Cancer 2021;124:102-14. [PMID: 33204027 DOI: 10.1038/s41416-020-01149-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
94 Bonizzi G, Cicalese A, Insinga A, Pelicci PG. The emerging role of p53 in stem cells. Trends Mol Med 2012;18:6-12. [PMID: 21907001 DOI: 10.1016/j.molmed.2011.08.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
95 Ferrari-Amorotti G, Fragliasso V, Esteki R, Prudente Z, Soliera AR, Cattelani S, Manzotti G, Grisendi G, Dominici M, Pieraccioli M, Raschellà G, Chiodoni C, Colombo MP, Calabretta B. Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion. Cancer Res 2013;73:235-45. [PMID: 23054398 DOI: 10.1158/0008-5472.CAN-12-1739] [Cited by in Crossref: 86] [Cited by in F6Publishing: 57] [Article Influence: 8.6] [Reference Citation Analysis]
96 Sinha N, Meher BR, Naik PP, Panda PK, Mukhapadhyay S, Maiti TK, Bhutia SK. p73 induction by Abrus agglutinin facilitates Snail ubiquitination to inhibit epithelial to mesenchymal transition in oral cancer. Phytomedicine 2019;55:179-90. [DOI: 10.1016/j.phymed.2018.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Kim SH, Kang JG, Kim CS, Ihm S, Choi MG, Yoo HJ, Lee SJ. Herbimycin A inhibits cell growth with reversal of epithelial–mesenchymal transition in anaplastic thyroid carcinoma cells. Biochemical and Biophysical Research Communications 2014;455:363-70. [DOI: 10.1016/j.bbrc.2014.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
98 Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li XY, Kang SE, Cha SY, Ryu JK, Na JM. p53 and microRNA-34 are suppressors of canonical Wnt signaling. Sci Signal. 2011;4:ra71. [PMID: 22045851 DOI: 10.1126/scisignal.2001744] [Cited by in Crossref: 148] [Cited by in F6Publishing: 200] [Article Influence: 13.5] [Reference Citation Analysis]
99 Morrison CD, Parvani JG, Schiemann WP. The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett 2013;341:30-40. [PMID: 23474494 DOI: 10.1016/j.canlet.2013.02.048] [Cited by in Crossref: 125] [Cited by in F6Publishing: 122] [Article Influence: 13.9] [Reference Citation Analysis]
100 Lee SY, Jeon HM, Ju MK, Jeong EK, Kim CH, Park HG, Han SI, Kang HS. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch. Oncotarget 2016;7:7925-39. [PMID: 26771232 DOI: 10.18632/oncotarget.6879] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
101 Heiler S, Wang Z, Zöller M. Pancreatic cancer stem cell markers and exosomes - the incentive push. World J Gastroenterol 2016; 22(26): 5971-6007 [PMID: 27468191 DOI: 10.3748/wjg.v22.i26.5971] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
102 Zhang XW, Wang XF, Ni SJ, Qin W, Zhao LQ, Hua RX, Lu YW, Li J, Dimri GP, Guo WJ. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop. J Pathol 2015;235:656-67. [PMID: 25382750 DOI: 10.1002/path.4478] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
103 Bastid J. EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations. Cancer Metastasis Rev 2012;31:277-83. [PMID: 22215472 DOI: 10.1007/s10555-011-9344-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
104 Meshkani SE, Kooshan N, Moghadam AB, Falanji F, Adli A, Baghbani-Arani F, Arian AG, Rad A. Signaling roadmap to epithelial-mesenchymal transition in pterygium, TWIST1 centralized. J Cell Physiol 2019;234:18146-55. [PMID: 30847945 DOI: 10.1002/jcp.28447] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
105 Yin J, Zheng G, Jia X, Zhang Z, Zhang W, Song Y, Xiong Y, He Z. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells. PLoS One 2013;8:e73268. [PMID: 24039897 DOI: 10.1371/journal.pone.0073268] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
106 Germani A, Foglio E, Capogrossi MC, Russo MA, Limana F. Generation of cardiac progenitor cells through epicardial to mesenchymal transition. J Mol Med (Berl) 2015;93:735-48. [PMID: 25943780 DOI: 10.1007/s00109-015-1290-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
107 Joseph JV, Conroy S, Tomar T, Eggens-Meijer E, Bhat K, Copray S, Walenkamp AM, Boddeke E, Balasubramanyian V, Wagemakers M, den Dunnen WF, Kruyt FA. TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis 2014;5:e1443. [PMID: 25275602 DOI: 10.1038/cddis.2014.395] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 11.8] [Reference Citation Analysis]
108 Wang B, Wang L, Mao J, Wen H, Xu L, Ren Y, Du H, Yang H. Mouse bone marrow mesenchymal stem cells with distinct p53 statuses display differential characteristics. Mol Med Rep 2020;21:2051-62. [PMID: 32186775 DOI: 10.3892/mmr.2020.11025] [Reference Citation Analysis]
109 Li Y, Guo W, Li X, Zhang J, Sun M, Tang Z, Ran W, Yang K, Huang G, Li L. Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers. Int J Oral Sci 2021;13:38. [PMID: 34785635 DOI: 10.1038/s41368-021-00145-1] [Reference Citation Analysis]
110 Solozobova V, Blattner C. p53 in stem cells. World J Biol Chem 2011; 2(9): 202-214 [PMID: 21949570 DOI: 10.4331/wjbc.v2.i9.202] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
111 Fu R, Han CF, Ni T, Di L, Liu LJ, Lv WC, Bi YR, Jiang N, He Y, Li HM, Wang S, Xie H, Chen BA, Wang XS, Weiss SJ, Lu T, Guo QL, Wu ZQ. A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours. Nat Commun 2019;10:3210. [PMID: 31324807 DOI: 10.1038/s41467-019-11278-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
112 Pavlakis E, Neumann M, Stiewe T. Extracellular Vesicles: Messengers of p53 in Tumor-Stroma Communication and Cancer Metastasis. Int J Mol Sci 2020;21:E9648. [PMID: 33348923 DOI: 10.3390/ijms21249648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
113 Parfenyev S, Singh A, Fedorova O, Daks A, Kulshreshtha R, Barlev NA. Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer. Cell Death Dis 2021;12:17. [PMID: 33414456 DOI: 10.1038/s41419-020-03327-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590-610. [PMID: 23102669 DOI: 10.1016/j.molonc.2012.09.006] [Cited by in Crossref: 673] [Cited by in F6Publishing: 659] [Article Influence: 67.3] [Reference Citation Analysis]
115 Toh TB, Lim JJ, Chow EK. Epigenetics in cancer stem cells. Mol Cancer. 2017;16:29. [PMID: 28148257 DOI: 10.1186/s12943-017-0596-9] [Cited by in Crossref: 138] [Cited by in F6Publishing: 129] [Article Influence: 27.6] [Reference Citation Analysis]
116 Hu Y, Yu J, Wang Q, Zhang L, Chen X, Cao Y, Zhao J, Xu Y, Jiang D, Wang Y, Xiong W. Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma. Mol Ther Oncolytics 2020;16:272-88. [PMID: 32181328 DOI: 10.1016/j.omto.2020.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
117 Ojima T, Kawami M, Yumoto R, Takano M. Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells. Toxicol Res 2021;37:293-300. [PMID: 34295794 DOI: 10.1007/s43188-020-00067-w] [Reference Citation Analysis]
118 Wang C, Li T, Yan F, Cai W, Zheng J, Jiang X, Sun J. Effect of simvastatin and microRNA-21 inhibitor on metastasis and progression of human salivary adenoid cystic carcinoma. Biomed Pharmacother 2018;105:1054-61. [PMID: 30021341 DOI: 10.1016/j.biopha.2018.05.157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
119 Sun N, Taguchi A, Hanash S. Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies. J Clin Med 2016;5:E109. [PMID: 27916872 DOI: 10.3390/jcm5120109] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
120 Pitolli C, Wang Y, Candi E, Shi Y, Melino G, Amelio I. p53-Mediated Tumor Suppression: DNA-Damage Response and Alternative Mechanisms. Cancers (Basel) 2019;11:E1983. [PMID: 31835405 DOI: 10.3390/cancers11121983] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
121 Isobe T, Hisamori S, Hogan DJ, Zabala M, Hendrickson DG, Dalerba P, Cai S, Scheeren F, Kuo AH, Sikandar SS, Lam JS, Qian D, Dirbas FM, Somlo G, Lao K, Brown PO, Clarke MF, Shimono Y. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. Elife 2014;3. [PMID: 25406066 DOI: 10.7554/eLife.01977] [Cited by in Crossref: 99] [Cited by in F6Publishing: 72] [Article Influence: 12.4] [Reference Citation Analysis]
122 Weng D, Chen JX, Li HH, Liu F, Zhou LD, Liu HP, Zheng RJ, Jiang Y, Liu ZH, Ge B. 2-aminopurine suppresses the TGF-β1-induced epithelial-mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis. Cell Death Discov 2018;4:17. [PMID: 29531814 DOI: 10.1038/s41420-017-0016-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
123 Coradini D, Fornili M, Ambrogi F, Boracchi P, Biganzoli E. TP53 mutation, epithelial-mesenchymal transition, and stemlike features in breast cancer subtypes. J Biomed Biotechnol 2012;2012:254085. [PMID: 22899882 DOI: 10.1155/2012/254085] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
124 Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms Controlling PD-L1 Expression in Cancer. Mol Cell. 2019;76:359-370. [PMID: 31668929 DOI: 10.1016/j.molcel.2019.09.030] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 25.0] [Reference Citation Analysis]
125 Wong DY, Ranganath T, Kasko AM. Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human Mesenchymal Stem Cells. PLoS One 2015;10:e0139307. [PMID: 26418040 DOI: 10.1371/journal.pone.0139307] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
126 Ubil E, Duan J, Pillai IC, Rosa-Garrido M, Wu Y, Bargiacchi F, Lu Y, Stanbouly S, Huang J, Rojas M, Vondriska TM, Stefani E, Deb A. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature 2014;514:585-90. [PMID: 25317562 DOI: 10.1038/nature13839] [Cited by in Crossref: 200] [Cited by in F6Publishing: 195] [Article Influence: 25.0] [Reference Citation Analysis]
127 Karsli Uzunbas G, Ahmed F, Sammons MA. Control of p53-dependent transcription and enhancer activity by the p53 family member p63. J Biol Chem 2019;294:10720-36. [PMID: 31113863 DOI: 10.1074/jbc.RA119.007965] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
128 Liang H, Gu Y, Li T, Zhang Y, Huangfu L, Hu M, Zhao D, Chen Y, Liu S, Dong Y, Li X, Lu Y, Yang B, Shan H. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis. Cell Death Dis 2014;5:e1238. [PMID: 24853416 DOI: 10.1038/cddis.2014.207] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 8.5] [Reference Citation Analysis]
129 Liu M, Zhou K, Huang Y, Cao Y. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway. J Exp Clin Cancer Res 2015;34:121. [PMID: 26467212 DOI: 10.1186/s13046-015-0235-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
130 Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V, McCawley LJ, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, Wolf GT, Dong C, Zhou BP, Brown DG, Colacci AM, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis 2015;36 Suppl 1:S128-59. [PMID: 26106135 DOI: 10.1093/carcin/bgv034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
131 Yu C, Chen F, Wang X, Cai Z, Yang M, Zhong Q, Feng J, Li J, Shen C, Wen Z. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting. J Exp Clin Cancer Res 2020;39:31. [PMID: 32028978 DOI: 10.1186/s13046-020-1530-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
132 Wen B, Zhu R, Jin H, Zhao K. Differential expression and role of miR-200 family in multiple tumors. Anal Biochem 2021;626:114243. [PMID: 33964251 DOI: 10.1016/j.ab.2021.114243] [Reference Citation Analysis]
133 Jafari SH, Saadatpour Z, Salmaninejad A, Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H, Kianmehr M. Breast cancer diagnosis: Imaging techniques and biochemical markers. J Cell Physiol 2018;233:5200-13. [PMID: 29219189 DOI: 10.1002/jcp.26379] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 26.0] [Reference Citation Analysis]
134 Wang Q, Selth LA, Callen DF. MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4. Oncotarget 2017;8:29914-24. [PMID: 28430625 DOI: 10.18632/oncotarget.15530] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
135 Markopoulos GS, Roupakia E, Marcu KB, Kolettas E. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation. Cells 2019;8:E1143. [PMID: 31557902 DOI: 10.3390/cells8101143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
136 Sun R, Lu X, Gong L, Jin F. TCTP promotes epithelial-mesenchymal transition in lung adenocarcinoma. Onco Targets Ther 2019;12:1641-53. [PMID: 30881019 DOI: 10.2147/OTT.S184555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
137 Fitriana M, Hwang WL, Chan PY, Hsueh TY, Liao TT. Roles of microRNAs in Regulating Cancer Stemness in Head and Neck Cancers. Cancers (Basel) 2021;13:1742. [PMID: 33917482 DOI: 10.3390/cancers13071742] [Reference Citation Analysis]
138 Luo W, Yao K. Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed. PLoS One 2013;8:e83135. [PMID: 24349446 DOI: 10.1371/journal.pone.0083135] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
139 Tayel SI, Fouda EAM, Gohar SF, Elshayeb EI, El-Sayed EH, El-Kousy SM. Potential role of MicroRNA 200c gene expression in assessment of colorectal cancer. Arch Biochem Biophys 2018;647:41-6. [PMID: 29660303 DOI: 10.1016/j.abb.2018.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
140 De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13:97-110. [PMID: 23344542 DOI: 10.1038/nrc3447] [Cited by in Crossref: 1460] [Cited by in F6Publishing: 1424] [Article Influence: 162.2] [Reference Citation Analysis]
141 Li Y, Nie Y, Cao J, Tu S, Lin Y, Du Y, Li Y. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. Mol Carcinog. 2014;53:219-229. [PMID: 23065816 DOI: 10.1002/mc.21966] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
142 Le Guillou S, Sdassi N, Laubier J, Passet B, Vilotte M, Castille J, Laloë D, Polyte J, Bouet S, Jaffrézic F. Overexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involution. PLoS One. 2012;7:e45727. [PMID: 23029204 DOI: 10.1371/journal.pone.0045727] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
143 Sun H, Zeng J, Miao Z, Lei KC, Huang C, Hu L, Su SM, Chan UI, Miao K, Zhang X, Zhang A, Guo S, Chen S, Meng Y, Deng M, Hao W, Lei H, Lin Y, Yang Z, Tang D, Wong KH, Zhang XD, Xu X, Deng CX. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing. Theranostics 2021;11:9967-87. [PMID: 34815798 DOI: 10.7150/thno.63995] [Reference Citation Analysis]
144 Teslow EA, Bao B, Dyson G, Legendre C, Mitrea C, Sakr W, Carpten JD, Powell I, Bollig-Fischer A. Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells. Mol Oncol 2018;12:1138-52. [PMID: 29741809 DOI: 10.1002/1878-0261.12316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
145 Yamaguchi J, Kokuryo T, Yokoyama Y, Ebata T, Ochiai Y, Nagino M. Premalignant pancreatic cells seed stealth metastasis in distant organs in mice. Oncogene 2021;40:2273-84. [PMID: 33649537 DOI: 10.1038/s41388-021-01706-8] [Reference Citation Analysis]
146 Dhillon AS, Tulchinsky E. FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer. Oncogene 2015;34:4421-8. [PMID: 25381818 DOI: 10.1038/onc.2014.374] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
147 Boufraqech M, Klubo-Gwiezdzinska J, Kebebew E. MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol Metab 2016;30:603-19. [PMID: 27923454 DOI: 10.1016/j.beem.2016.10.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
148 Xu H, Mei Q, Xiong C, Zhao J. Tumor-suppressing effects of miR-141 in human osteosarcoma. Cell Biochem Biophys 2014;69:319-25. [PMID: 24307282 DOI: 10.1007/s12013-013-9801-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
149 Rustighi A, Zannini A, Tiberi L, Sommaggio R, Piazza S, Sorrentino G, Nuzzo S, Tuscano A, Eterno V, Benvenuti F, Santarpia L, Aifantis I, Rosato A, Bicciato S, Zambelli A, Del Sal G. Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO Mol Med 2014;6:99-119. [PMID: 24357640 DOI: 10.1002/emmm.201302909] [Cited by in Crossref: 96] [Cited by in F6Publishing: 92] [Article Influence: 10.7] [Reference Citation Analysis]
150 Cao ZZ, Ao YJ, Zhou SH. The role of cancer stromal fibroblasts in mediating the effects of tobacco-induced cancer cell growth. Cancer Cell Int 2021;21:707. [PMID: 34953503 DOI: 10.1186/s12935-021-02414-9] [Reference Citation Analysis]
151 Su W, Xu M, Chen X, Nie L, Chen N, Gong J, Zhang M, Su Z, Huang L, Zhou Q. MiR200c targets IRS1 and suppresses prostate cancer cell growth. Prostate 2015;75:855-62. [PMID: 25683382 DOI: 10.1002/pros.22968] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
152 Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, Capogrossi MC. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ. 2011;18:1628-1639. [PMID: 21527937 DOI: 10.1038/cdd.2011.42] [Cited by in Crossref: 295] [Cited by in F6Publishing: 290] [Article Influence: 26.8] [Reference Citation Analysis]
153 Cole AJ, Fayomi AP, Anyaeche VI, Bai S, Buckanovich RJ. An evolving paradigm of cancer stem cell hierarchies: therapeutic implications. Theranostics 2020;10:3083-98. [PMID: 32194856 DOI: 10.7150/thno.41647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
154 Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, Yuan J, Wang M, Chen D, Sun Y, Woodward WA, Liu Y, Dean DC, Liang H, Hu Y, Ang KK, Hung MC, Chen J, Ma L. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol 2014;16:864-75. [PMID: 25086746 DOI: 10.1038/ncb3013] [Cited by in Crossref: 233] [Cited by in F6Publishing: 228] [Article Influence: 29.1] [Reference Citation Analysis]
155 Zhang Q, Zhuang J, Deng Y, Yang L, Cao W, Chen W, Lin T, Lv X, Yu H, Xue Y, Guo H. miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness. Theranostics 2017;7:4777-90. [PMID: 29187903 DOI: 10.7150/thno.21713] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
156 Xiao J, He X. Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:8781-94. [PMID: 34849030 DOI: 10.2147/CMAR.S336265] [Reference Citation Analysis]
157 Kansakar U, Wang W, Markovic V, Sossey-Alaoui K. Elucidating the molecular signaling pathways of WAVE3. Ann Transl Med 2020;8:900. [PMID: 32793744 DOI: 10.21037/atm.2020.02.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell Tissue Res 2012;347:85-101. [PMID: 21691718 DOI: 10.1007/s00441-011-1199-1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 140] [Article Influence: 13.5] [Reference Citation Analysis]
159 Le Guillou S, Marthey S, Laloë D, Laubier J, Mobuchon L, Leroux C, Le Provost F. Characterisation and comparison of lactating mouse and bovine mammary gland miRNomes. PLoS One 2014;9:e91938. [PMID: 24658750 DOI: 10.1371/journal.pone.0091938] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
160 Xie X, Piao L, Bullock BN, Smith A, Su T, Zhang M, Teknos TN, Arora PS, Pan Q. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma. Oncogene 2014;33:1037-46. [PMID: 23474763 DOI: 10.1038/onc.2013.25] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
161 Klimczak M. Oncogenesis and induced pluripotency - commonalities of signalling pathways. Contemp Oncol (Pozn) 2015;19:A16-21. [PMID: 25691817 DOI: 10.5114/wo.2014.47133] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
162 Bai F, Zhang LH, Liu X, Wang C, Zheng C, Sun J, Li M, Zhu WG, Pei XH. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer. Theranostics 2021;11:8218-33. [PMID: 34373738 DOI: 10.7150/thno.59280] [Reference Citation Analysis]
163 Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel J, Cottu P, Sastre-garau X, Mechta-grigoriou F. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011;17:1627-35. [DOI: 10.1038/nm.2512] [Cited by in Crossref: 312] [Cited by in F6Publishing: 290] [Article Influence: 28.4] [Reference Citation Analysis]
164 Heery R, Finn SP, Cuffe S, Gray SG. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel). 2017;9. [PMID: 28430163 DOI: 10.3390/cancers9040038] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 17.6] [Reference Citation Analysis]
165 Zhang M, Liang XH, Tang YL. [Advances in the molecular mechanisms of perineural invasion in salivary adenoid cystic carcinoma]. Hua Xi Kou Qiang Yi Xue Za Zhi 2018;36:204-11. [PMID: 29779285 DOI: 10.7518/hxkq.2018.02.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
166 Humphries B, Yang C. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget 2015;6:6472-98. [PMID: 25762624 DOI: 10.18632/oncotarget.3052] [Cited by in Crossref: 183] [Cited by in F6Publishing: 195] [Article Influence: 30.5] [Reference Citation Analysis]
167 Zeeshan R, Mutahir Z. Cancer metastasis - tricks of the trade. Bosn J Basic Med Sci 2017;17:172-82. [PMID: 28278128 DOI: 10.17305/bjbms.2017.1908] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
168 Strauss R, Hamerlik P, Lieber A, Bartek J. Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer. Mol Ther. 2012;20:887-897. [PMID: 22314288 DOI: 10.1038/mt.2012.2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
169 Fan X, Chen W, Fu Z, Zeng L, Yin Y, Yuan H. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells. Oncol Lett 2017;14:5069-76. [PMID: 29142594 DOI: 10.3892/ol.2017.6867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
170 Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, Materazzi G, Sellari-Franceschini S, Ribechini A, Torregrossa L, Basolo F, Vitti P, Elisei R. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol 2017;13:644-60. [PMID: 28707679 DOI: 10.1038/nrendo.2017.76] [Cited by in Crossref: 148] [Cited by in F6Publishing: 148] [Article Influence: 29.6] [Reference Citation Analysis]
171 Ivanova E, Le Guillou S, Hue-Beauvais C, Le Provost F. Epigenetics: New Insights into Mammary Gland Biology. Genes (Basel) 2021;12:231. [PMID: 33562534 DOI: 10.3390/genes12020231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
172 Zhang G, Zhang W, Li B, Stringer-Reasor E, Chu C, Sun L, Bae S, Chen D, Wei S, Jiao K, Yang WH, Cui R, Liu R, Wang L. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer. Breast Cancer Res 2017;19:73. [PMID: 28637482 DOI: 10.1186/s13058-017-0858-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 8.2] [Reference Citation Analysis]
173 Hwang-Verslues WW, Lee WH, Lee EY. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells. J Mol Biomark Diagn 2012;Suppl 8:6. [PMID: 24977105 DOI: 10.4172/2155-9929.S8-006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Chang C, Chao C, Xia W, Yang J, Xiong Y, Li C, Yu W, Rehman SK, Hsu JL, Lee H, Liu M, Chen C, Yu D, Hung M. Erratum: p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011;13:1466-1466. [DOI: 10.1038/ncb2401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
175 Luo WR, Yao KT. Cancer stem cell characteristics, ALDH1 expression in the invasive front of nasopharyngeal carcinoma. Virchows Arch 2014;464:35-43. [PMID: 24248285 DOI: 10.1007/s00428-013-1508-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
176 Hau A, Ceppi P, Peter ME. CD95 is part of a let-7/p53/miR-34 regulatory network. PLoS One 2012;7:e49636. [PMID: 23166734 DOI: 10.1371/journal.pone.0049636] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
177 Howe EN, Cochrane DR, Richer JK. The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia. 2012;17:65-77. [PMID: 22350980 DOI: 10.1007/s10911-012-9244-6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
178 Termén S, Tan E, Heldin C, Moustakas A. p53 regulates epithelial-mesenchymal transition induced by transforming growth factor β. J Cell Physiol 2013;228:801-13. [DOI: 10.1002/jcp.24229] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
179 Qin QP, Wang SL, Tan MX, Wang ZF, Luo DM, Zou BQ, Liu YC, Yao PF, Liang H. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway. Eur J Med Chem 2018;158:106-22. [PMID: 30205260 DOI: 10.1016/j.ejmech.2018.09.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
180 Khan S, Shukla S, Sinha S, Meeran SM. Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer: CENTCHROMAN INDUCES EPIGENETIC ALTERATIONS IN BREAST CANCER. Mol Carcinog 2016;55:1747-60. [DOI: 10.1002/mc.22424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
181 Ding C, Li Y, Wang S, Xing C, Chen L, Zhang H, Wang Y, Dai M. ROBO2 hampers malignant biological behavior and predicts a better prognosis in pancreatic adenocarcinoma. Scand J Gastroenterol 2021;56:955-64. [PMID: 34148491 DOI: 10.1080/00365521.2021.1930144] [Reference Citation Analysis]
182 Drápela S, Bouchal J, Jolly MK, Culig Z, Souček K. ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance. Front Mol Biosci 2020;7:36. [PMID: 32266287 DOI: 10.3389/fmolb.2020.00036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
183 Abe I, Lam AK. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics. Curr Oncol Rep 2021;23:31. [PMID: 33582932 DOI: 10.1007/s11912-021-01019-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu BC, Chen YW, Huang PI, Lo WL. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Oral Oncol 2013;49:34-41. [PMID: 22892238 DOI: 10.1016/j.oraloncology.2012.07.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
185 Shetzer Y, Solomon H, Koifman G, Molchadsky A, Horesh S, Rotter V. The paradigm of mutant p53-expressing cancer stem cells and drug resistance. Carcinogenesis. 2014;35:1196-1208. [PMID: 24658181 DOI: 10.1093/carcin/bgu073] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
186 Sengupta D, Deb M, Kar S, Pradhan N, Parbin S, Kirtana R, Singh SP, Suma SG, Niharika, Roy A, Manna S, Saha P, Chakraborty P, Dash S, Kausar C, Patra SK. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention. Semin Cancer Biol 2021;72:46-64. [PMID: 32497683 DOI: 10.1016/j.semcancer.2020.05.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
187 Yabasin IB, Sanches JGP, Ibrahim MM, Huidan J, Williams W, Lu ZL, Wen Q. Cisatracurium Retards Cell Migration and Invasion Upon Upregulation of p53 and Inhibits the Aggressiveness of Colorectal Cancer. Front Physiol 2018;9:941. [PMID: 30108509 DOI: 10.3389/fphys.2018.00941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
188 Wang J, Liu D, Sun Z, Ye T, Li J, Zeng B, Zhao Q, Rosie Xing H. Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53. Cell Death Dis 2021;12:98. [PMID: 33468994 DOI: 10.1038/s41419-021-03392-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
189 Pan Q, Meng L, Ye J, Wei X, Shang Y, Tian Y, He Y, Peng Z, Chen L, Chen W, Bian X, Wang R. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT). Cancer Lett 2017;392:26-38. [PMID: 28163188 DOI: 10.1016/j.canlet.2017.01.039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
190 Hünten S, Siemens H, Kaller M, Hermeking H. The p53/microRNA Network in Cancer: Experimental and Bioinformatics Approaches. In: Schmitz U, Wolkenhauer O, Vera J, editors. MicroRNA Cancer Regulation. Dordrecht: Springer Netherlands; 2013. pp. 77-101. [DOI: 10.1007/978-94-007-5590-1_5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
191 Ceppi P, Peter ME. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells. Oncogene 2014;33:269-78. [PMID: 23455327 DOI: 10.1038/onc.2013.55] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
192 Navalkar A, Pandey S, Singh N, Patel K, Datta D, Mohanty B, Jadhav S, Chaudhari P, Maji SK. Direct evidence of cellular transformation by prion-like p53 amyloid infection. J Cell Sci 2021;134:jcs258316. [PMID: 34085695 DOI: 10.1242/jcs.258316] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
193 Lim SB, Lim CT, Lim WT. Single-Cell Analysis of Circulating Tumor Cells: Why Heterogeneity Matters. Cancers (Basel) 2019;11:E1595. [PMID: 31635038 DOI: 10.3390/cancers11101595] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
194 Soleimani T, Falsafi N, Fallahi H. Dissection of Regulatory Elements During Direct Conversion of Somatic Cells Into Neurons. J Cell Biochem 2017;118:3158-70. [DOI: 10.1002/jcb.25944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
195 Kincaid RP, Burke JM, Sullivan CS. RNA virus microRNA that mimics a B-cell oncomiR. Proc Natl Acad Sci U S A 2012;109:3077-82. [PMID: 22308400 DOI: 10.1073/pnas.1116107109] [Cited by in Crossref: 177] [Cited by in F6Publishing: 172] [Article Influence: 17.7] [Reference Citation Analysis]
196 Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Seminars in Cancer Biology 2012;22:194-207. [DOI: 10.1016/j.semcancer.2012.02.013] [Cited by in Crossref: 306] [Cited by in F6Publishing: 280] [Article Influence: 30.6] [Reference Citation Analysis]
197 Wang YL, Wu S, Jiang B, Yin FF, Zheng SS, Hou SC. Role of MicroRNAs in Prostate Cancer Pathogenesis. Clin Genitourin Cancer 2015;13:261-70. [PMID: 25733057 DOI: 10.1016/j.clgc.2015.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
198 Zhang YQ, Zhang F, Zeng YZ, Chen M, Huang WH, Wu JD, Chen WL, Gao WL, Bai JW, Yang RQ, Zeng HC, Wei XL, Zhang GJ. Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer. Front Oncol 2021;11:628814. [PMID: 34249678 DOI: 10.3389/fonc.2021.628814] [Reference Citation Analysis]
199 Chen X, Zeng K, Xu M, Liu X, Hu X, Xu T, He B, Pan Y, Sun H, Wang S. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2. Cell Death Dis 2019;10:131. [PMID: 30755600 DOI: 10.1038/s41419-018-1188-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 13.3] [Reference Citation Analysis]
200 Morris EV, Cerundolo L, Lu M, Verrill C, Fritzsche F, White MJ, Thalmann GN, ten Donkelaar CS, Ratnayaka I, Salter V, Hamdy FC, Lu X, Bryant RJ. Nuclear iASPP may facilitate prostate cancer progression. Cell Death Dis 2014;5:e1492. [PMID: 25341046 DOI: 10.1038/cddis.2014.442] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
201 Eriksson M, Ambroise G, Ouchida AT, Lima Queiroz A, Smith D, Gimenez-Cassina A, Iwanicki MP, Muller PA, Norberg E, Vakifahmetoglu-Norberg H. Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism. Mol Cell Biol 2017;37:e00328-17. [PMID: 28993478 DOI: 10.1128/MCB.00328-17] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
202 Jin H, Xue L, Mo L, Zhang D, Guo X, Xu J, Li J, Peng M, Zhao X, Zhong M, Xu D, Wu XR, Huang H, Huang C. Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer. Cell Adh Migr 2019;13:236-48. [PMID: 31240993 DOI: 10.1080/19336918.2019.1633851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
203 Liu L, Zang J, Chen X, Yang G, Zhu Y, Wu Y, Li T. Role of miR-124 and miR-141 in the regulation of vascular reactivity and the relationship to RhoA and Rac1 after hemorrhage and hypoxia. Am J Physiol Heart Circ Physiol 2016;310:H206-16. [PMID: 26453334 DOI: 10.1152/ajpheart.00651.2014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
204 Yang-Hartwich Y, Tedja R, Roberts CM, Goodner-Bingham J, Cardenas C, Gurea M, Sumi NJ, Alvero AB, Glackin CA, Mor G. p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT. Mol Cancer Res 2019;17:153-64. [PMID: 30131448 DOI: 10.1158/1541-7786.MCR-18-0238] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
205 Wu M, Sun Y, Xu F, Liang Y, Liu H, Yi Y. Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs. J Cancer. 2019;10:1077-1085. [PMID: 30854114 DOI: 10.7150/jca.29440] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
206 Chen H, Pan J, Zhang L, Chen L, Qi H, Zhong M, Shi X, Du J, Li Q. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways. Eur J Pharmacol 2018;825:133-42. [PMID: 29476880 DOI: 10.1016/j.ejphar.2018.02.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
207 Baghi N, Bakhshinejad B, Keshavarz R, Babashah S, Sadeghizadeh M. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells. Gene 2018;670:55-62. [PMID: 29753810 DOI: 10.1016/j.gene.2018.05.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
208 Orang AV, Petersen J, McKinnon RA, Michael MZ. Micromanaging aerobic respiration and glycolysis in cancer cells. Mol Metab 2019;23:98-126. [PMID: 30837197 DOI: 10.1016/j.molmet.2019.01.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
209 Giannoni E, Parri M, Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid Redox Signal. 2012;16:1248-1263. [PMID: 21929373 DOI: 10.1089/ars.2011.4280] [Cited by in Crossref: 117] [Cited by in F6Publishing: 118] [Article Influence: 10.6] [Reference Citation Analysis]
210 Chen Y, Zhang L. Members of the microRNA-200 family are promising therapeutic targets in cancer. Exp Ther Med 2017;14:10-7. [PMID: 28672887 DOI: 10.3892/etm.2017.4488] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
211 Powell E, Piwnica-Worms D, Piwnica-Worms H. Contribution of p53 to metastasis. Cancer Discov 2014;4:405-14. [PMID: 24658082 DOI: 10.1158/2159-8290.CD-13-0136] [Cited by in Crossref: 182] [Cited by in F6Publishing: 120] [Article Influence: 22.8] [Reference Citation Analysis]
212 Rahimi M, Sharifi-Zarchi A, Firouzi J, Azimi M, Zarghami N, Alizadeh E, Ebrahimi M. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells. J Cell Mol Med 2019;23:2442-56. [PMID: 30710426 DOI: 10.1111/jcmm.14090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
213 Yang J, Wu SP, Wang WJ, Jin ZR, Miao XB, Wu Y, Gou DM, Liu QZ, Yao KT. A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer. Exp Cell Res 2020;391:111817. [PMID: 32179097 DOI: 10.1016/j.yexcr.2020.111817] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
214 Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 2014;7:re8. [PMID: 25249658 DOI: 10.1126/scisignal.2005189] [Cited by in Crossref: 709] [Cited by in F6Publishing: 743] [Article Influence: 88.6] [Reference Citation Analysis]
215 Nallamshetty S, Chan SY, Loscalzo J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med 2013;64:20-30. [PMID: 23712003 DOI: 10.1016/j.freeradbiomed.2013.05.022] [Cited by in Crossref: 172] [Cited by in F6Publishing: 166] [Article Influence: 19.1] [Reference Citation Analysis]
216 Tomei S, Volontè A, Ravindran S, Mazzoleni S, Wang E, Galli R, Maccalli C. MicroRNA Expression Profile Distinguishes Glioblastoma Stem Cells from Differentiated Tumor Cells. J Pers Med 2021;11:264. [PMID: 33916317 DOI: 10.3390/jpm11040264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene. 2013;32:296-306. [PMID: 22370643 DOI: 10.1038/onc.2012.58] [Cited by in Crossref: 196] [Cited by in F6Publishing: 209] [Article Influence: 19.6] [Reference Citation Analysis]
218 Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, Yang Y, Chen X, Liu G. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology. 2013;303:139-146. [PMID: 23146760 DOI: 10.1016/j.tox.2012.09.017] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 10.0] [Reference Citation Analysis]
219 Takahashi RU, Takeshita F, Honma K, Ono M, Kato K, Ochiya T. Ribophorin II regulates breast tumor initiation and metastasis through the functional suppression of GSK3β. Sci Rep 2013;3:2474. [PMID: 23959174 DOI: 10.1038/srep02474] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
220 Zhang Y, Xu B, Zhang XP. Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer. Onco Targets Ther 2018;11:4263-70. [PMID: 30100733 DOI: 10.2147/OTT.S165156] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
221 Xia H, Hui KM. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012;19:723-730. [PMID: 22975591 DOI: 10.1038/cgt.2012.58] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
222 Araki K, Ebata T, Guo AK, Tobiume K, Wolf SJ, Kawauchi K. p53 regulates cytoskeleton remodeling to suppress tumor progression. Cell Mol Life Sci 2015;72:4077-94. [PMID: 26206378 DOI: 10.1007/s00018-015-1989-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
223 Chiche A, Moumen M, Petit V, Jonkers J, Medina D, Deugnier MA, Faraldo MM, Glukhova MA. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. Stem Cells 2013;31:1857-67. [PMID: 23712598 DOI: 10.1002/stem.1429] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
224 Pal AS, Kasinski AL. Animal Models to Study MicroRNA Function. Adv Cancer Res 2017;135:53-118. [PMID: 28882225 DOI: 10.1016/bs.acr.2017.06.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
225 Voon DC, Huang RY, Jackson RA, Thiery JP. The EMT spectrum and therapeutic opportunities. Mol Oncol 2017;11:878-91. [PMID: 28544151 DOI: 10.1002/1878-0261.12082] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
226 Bonetti P, Climent M, Panebianco F, Tordonato C, Santoro A, Marzi MJ, Pelicci PG, Ventura A, Nicassio F. Dual role for miR-34a in the control of early progenitor proliferation and commitment in the mammary gland and in breast cancer. Oncogene 2019;38:360-74. [PMID: 30093634 DOI: 10.1038/s41388-018-0445-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
227 Lin CP, Choi YJ, Hicks GG, He L. The emerging functions of the p53-miRNA network in stem cell biology. Cell Cycle 2012;11:2063-72. [PMID: 22580472 DOI: 10.4161/cc.20207] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
228 Samimi H, Zaki Dizaji M, Ghadami M, Shahzadeh Fazeli A, Khashayar P, Soleimani M, Larijani B, Haghpanah V. MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin. J Diabetes Metab Disord 2013;12:31. [PMID: 23815851 DOI: 10.1186/2251-6581-12-31] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
229 Otsuka K, Ochiya T. Genetic networks lead and follow tumor development: microRNA regulation of cell cycle and apoptosis in the p53 pathways. Biomed Res Int 2014;2014:749724. [PMID: 25302307 DOI: 10.1155/2014/749724] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
230 Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci. 2012;69:3429-3456. [PMID: 22945800 DOI: 10.1007/s00018-012-1122-2] [Cited by in Crossref: 322] [Cited by in F6Publishing: 313] [Article Influence: 32.2] [Reference Citation Analysis]
231 Gocan AG, Bachg D, Schindler AE, Rohr UD. Managing immunity in resistant cancer patients correlates to survival: results and discussion of a pilot study. Horm Mol Biol Clin Investig 2011;8:455-69. [PMID: 25961344 DOI: 10.1515/HMBCI.2011.122] [Reference Citation Analysis]
232 Gao Q, Yuan Y, Gan HZ, Peng Q. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol Lett. 2015;9:2381-2387. [PMID: 26137075 DOI: 10.3892/ol.2015.2988] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
233 Bertolotto C. Melanoma: from melanocyte to genetic alterations and clinical options. Scientifica (Cairo) 2013;2013:635203. [PMID: 24416617 DOI: 10.1155/2013/635203] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
234 Schob S, Meyer HJ, Pazaitis N, Schramm D, Bremicker K, Exner M, Höhn AK, Garnov N, Surov A. ADC Histogram Analysis of Cervical Cancer Aids Detecting Lymphatic Metastases—a Preliminary Study. Mol Imaging Biol 2017;19:953-62. [DOI: 10.1007/s11307-017-1073-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
235 de Barrios O, Győrffy B, Fernández-Aceñero MJ, Sánchez-Tilló E, Sánchez-Moral L, Siles L, Esteve-Arenys A, Roué G, Casal JI, Darling DS, Castells A, Postigo A. ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1. Gut 2017;66:666-82. [PMID: 27965283 DOI: 10.1136/gutjnl-2015-310838] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
236 Abaurrea A, Araujo AM, Caffarel MM. The Role of the IL-6 Cytokine Family in Epithelial-Mesenchymal Plasticity in Cancer Progression. Int J Mol Sci 2021;22:8334. [PMID: 34361105 DOI: 10.3390/ijms22158334] [Reference Citation Analysis]
237 Abdalla F, Singh B, Bhat HK. MicroRNAs and gene regulation in breast cancer. J Biochem Mol Toxicol 2020;34. [DOI: 10.1002/jbt.22567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
238 Da Cruz Paula A, Leitão C, Marques O, Rosa AM, Santos AH, Rêma A, de Fátima Faria M, Rocha A, Costa JL, Lima M, Lopes C. Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions. Virchows Arch 2017;470:311-22. [PMID: 28116522 DOI: 10.1007/s00428-017-2068-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
239 Zhang J, Shao X, Sun H, Liu K, Ding Z, Chen J, Fang L, Su W, Hong Y, Li H, Li H. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling. Oncotarget 2016;7:61036-53. [PMID: 27506933 DOI: 10.18632/oncotarget.11062] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
240 Grespi F, Landré V, Molchadsky A, Di Daniele N, Marsella LT, Melino G, Rotter V. Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells. Cell Death Dis 2016;7:e2567. [PMID: 28032868 DOI: 10.1038/cddis.2016.419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
241 Guo F, Parker Kerrigan BC, Yang D, Hu L, Shmulevich I, Sood AK, Xue F, Zhang W. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions. J Hematol Oncol. 2014;7:19. [PMID: 24598126 DOI: 10.1186/1756-8722-7-19] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 9.9] [Reference Citation Analysis]
242 Khalife H, Skafi N, Fayyad-Kazan M, Badran B. MicroRNAs in breast cancer: New maestros defining the melody. Cancer Genet 2020;246-247:18-40. [PMID: 32805688 DOI: 10.1016/j.cancergen.2020.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
243 Lee JH, Poudel B, Ki HH, Nepali S, Lee YM, Shin JS, Kim DK. Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1. Sci Rep 2018;8:4908. [PMID: 29559654 DOI: 10.1038/s41598-018-23240-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
244 Singh S, Chakrabarti R. Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells. J Clin Med 2019;8:E642. [PMID: 31075939 DOI: 10.3390/jcm8050642] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
245 Parisi F, Vidal M. Epithelial delamination and migration: lessons from Drosophila. Cell Adh Migr 2011;5:366-72. [PMID: 21836393 DOI: 10.4161/cam.5.4.17524] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
246 Liu JC, Voisin V, Wang S, Wang DY, Jones RA, Datti A, Uehling D, Al-awar R, Egan SE, Bader GD, Tsao M, Mak TW, Zacksenhaus E. Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K. EMBO Mol Med 2014;6:1542-60. [PMID: 25330770 DOI: 10.15252/emmm.201404402] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 9.9] [Reference Citation Analysis]
247 Dambal S, Shah M, Mihelich B, Nonn L. The microRNA-183 cluster: the family that plays together stays together. Nucleic Acids Res 2015;43:7173-88. [PMID: 26170234 DOI: 10.1093/nar/gkv703] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 15.4] [Reference Citation Analysis]
248 Schubert J, Brabletz T. p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression. Cell Res 2011;21:705-7. [PMID: 21483453 DOI: 10.1038/cr.2011.62] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
249 Ber S, Lee C, Voiculescu O, Surani MA. Dedifferentiation of foetal CNS stem cells to mesendoderm-like cells through an EMT process. PLoS One 2012;7:e30759. [PMID: 22276221 DOI: 10.1371/journal.pone.0030759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
250 Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res. 2012;72:4883-4889. [PMID: 23002209 DOI: 10.1158/0008-5472.can-12-1223] [Cited by in Crossref: 201] [Cited by in F6Publishing: 123] [Article Influence: 20.1] [Reference Citation Analysis]
251 Pretzsch E, Bösch F, Neumann J, Ganschow P, Bazhin A, Guba M, Werner J, Angele M. Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread. J Oncol 2019;2019:7407190. [PMID: 31641356 DOI: 10.1155/2019/7407190] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
252 Asli NS, Harvey RP. Epithelial to mesenchymal transition as a portal to stem cell characters embedded in gene networks. Bioessays 2013;35:191-200. [DOI: 10.1002/bies.201200089] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
253 Kim J, Wu L, Zhao JC, Jin HJ, Yu J. TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c. Oncogene 2014;33:5183-92. [PMID: 24186205 DOI: 10.1038/onc.2013.461] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
254 Yuan XW, Wang DM, Hu Y, Tang YN, Shi WW, Guo XJ, Song JG. Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition. J Biol Chem 2013;288:31206-16. [PMID: 24022481 DOI: 10.1074/jbc.M113.480285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
255 Abdeen SK, Aqeilan RI. Decoding the link between WWOX and p53 in aggressive breast cancer. Cell Cycle 2019;18:1177-86. [PMID: 31075076 DOI: 10.1080/15384101.2019.1616998] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
256 da Cruz AT, Hunger A, de Melo FHM, Monteiro AC, Paré GC, Lai D, Alves-Fernandes DK, Ayub ALP, Cordero EM, Filho JFDS, Schneider-Stock R, Strauss BE, Tron V, Jasiulionis MG. miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients. Neoplasia 2021;23:823-34. [PMID: 34246986 DOI: 10.1016/j.neo.2021.05.015] [Reference Citation Analysis]
257 Xie Y, Liu S, Lu W, Yang Q, Williams KD, Binhazim AA, Carver BS, Matusik RJ, Chen Z. Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis. Mol Oncol 2014;8:1355-64. [PMID: 24910389 DOI: 10.1016/j.molonc.2014.05.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
258 Mao P, Li J, Huang Y, Wu S, Pang X, He W, Liu X, Slutsky AS, Zhang H, Li Y. MicroRNA-19b Mediates Lung Epithelial-Mesenchymal Transition via Phosphatidylinositol-3,4,5-Trisphosphate 3-Phosphatase in Response to Mechanical Stretch. Am J Respir Cell Mol Biol 2017;56:11-9. [PMID: 27508324 DOI: 10.1165/rcmb.2015-0377OC] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
259 Yang C, Jin K, Tong Y, Cho WC. Therapeutic potential of cancer stem cells. Med Oncol 2015;32:619. [PMID: 25920610 DOI: 10.1007/s12032-015-0619-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
260 Wang G, Cao X, Lai S, Luo X, Feng Y, Wu J, Ning Q, Xia X, Wang J, Gong J, Hu J. Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer. Oncogene 2015;34:912-21. [PMID: 24632606 DOI: 10.1038/onc.2014.30] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
261 Cao D, Di M, Liang J, Shi S, Tan Q, Wang Z. MicroRNA-183 in Cancer Progression. J Cancer 2020;11:1315-24. [PMID: 32047538 DOI: 10.7150/jca.39044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
262 Campo L, Zhang C, Breuer EK. EMT-Inducing Molecular Factors in Gynecological Cancers. Biomed Res Int 2015;2015:420891. [PMID: 26356073 DOI: 10.1155/2015/420891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
263 Bi M, Zhao S, Said JW, Merino MJ, Adeniran AJ, Xie Z, Nawaf CB, Choi J, Belldegrun AS, Pantuck AJ, Kluger HM, Bilgüvar K, Lifton RP, Shuch B. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma. Proc Natl Acad Sci U S A 2016;113:2170-5. [PMID: 26864202 DOI: 10.1073/pnas.1525735113] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 12.2] [Reference Citation Analysis]
264 Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer. 2011;2:466-474. [PMID: 21779514 DOI: 10.1177/1947601911408889] [Cited by in Crossref: 449] [Cited by in F6Publishing: 414] [Article Influence: 40.8] [Reference Citation Analysis]
265 Wang G, Guo X, Hong W, Liu Q, Wei T, Lu C, Gao L, Ye D, Zhou Y, Chen J. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci U S A. 2013;110:2858-2863. [PMID: 23386720 DOI: 10.1073/pnas.1212769110] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
266 Lee H, Hwang K, Choi K. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process. Molecular and Cellular Endocrinology 2017;457:103-13. [DOI: 10.1016/j.mce.2016.12.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
267 Zhai H, Ju J. Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics. Front Genet 2011;2:00078. [PMID: 22114584 DOI: 10.3389/fgene.2011.00078] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
268 Rehman SK, Li SH, Wyszomierski SL, Wang Q, Li P, Sahin O, Xiao Y, Zhang S, Xiong Y, Yang J, Wang H, Guo H, Zhang JD, Medina D, Muller WJ, Yu D. 14-3-3ζ orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation. Cancer Res 2014;74:363-73. [PMID: 24197133 DOI: 10.1158/0008-5472.CAN-13-2016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
269 Ansieau S, Courtois-Cox S, Morel AP, Puisieux A. Failsafe program escape and EMT: a deleterious partnership. Semin Cancer Biol 2011;21:392-6. [PMID: 21986518 DOI: 10.1016/j.semcancer.2011.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 0.1] [Reference Citation Analysis]
270 Mei Q, Li X, Guo M, Fu X, Han W. The miRNA network: micro-regulator of cell signaling in cancer. Expert Rev Anticancer Ther. 2014;14:1515-1527. [PMID: 25163801 DOI: 10.1586/14737140.2014.953935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
271 Salnikov AV, Liu L, Platen M, Gladkich J, Salnikova O, Ryschich E, Mattern J, Moldenhauer G, Werner J, Schemmer P, Büchler MW, Herr I. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One 2012;7:e46391. [PMID: 23050024 DOI: 10.1371/journal.pone.0046391] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 9.2] [Reference Citation Analysis]
272 Wang Z, Jiang Y, Guan D, Li J, Yin H, Pan Y, Xie D, Chen Y. Critical roles of p53 in epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma cells. PLoS One. 2013;8:e72846. [PMID: 24023784 DOI: 10.1371/journal.pone.0072846] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
273 Kim NH, Song SH, Choi YH, Hwang KH, Yun JS, Song H, Cha SY, Cho SB, Lee I, Kim HS, Yook JI. Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer. Int J Mol Sci 2021;22:9589. [PMID: 34502497 DOI: 10.3390/ijms22179589] [Reference Citation Analysis]
274 Fuziwara CS, Kimura ET. MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology. Int J Endocrinol 2014;2014:743450. [PMID: 25202329 DOI: 10.1155/2014/743450] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
275 Sivadas VP, Kannan S. The microRNA networks of TGFβ signaling in cancer. Tumour Biol 2014;35:2857-69. [PMID: 24323563 DOI: 10.1007/s13277-013-1481-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
276 Goto A, Dobashi Y, Tsubochi H, Maeda D, Ooi A. MicroRNAs associated with increased AKT gene number in human lung carcinoma. Hum Pathol 2016;56:1-10. [PMID: 27189341 DOI: 10.1016/j.humpath.2016.04.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
277 Deng G, Sui G. Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci 2013;14:18319-49. [PMID: 24013378 DOI: 10.3390/ijms140918319] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 8.3] [Reference Citation Analysis]
278 Dong P, Ihira K, Hamada J, Watari H, Yamada T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N. Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors. Oncotarget 2015;6:19968-75. [PMID: 26343523 DOI: 10.18632/oncotarget.4847] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
279 Takagi R, Yamato M, Murakami D, Sugiyama H, Okano T. Low calcium culture condition induces mesenchymal cell-like phenotype in normal human epidermal keratinocytes. Biochemical and Biophysical Research Communications 2011;412:226-31. [DOI: 10.1016/j.bbrc.2011.07.069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
280 Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012;482:347-355. [PMID: 22337054 DOI: 10.1038/nature10888] [Cited by in Crossref: 742] [Cited by in F6Publishing: 722] [Article Influence: 74.2] [Reference Citation Analysis]
281 Soubani O, Ali AS, Logna F, Ali S, Philip PA, Sarkar FH. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis. 2012;33:1563-1571. [PMID: 22637745 DOI: 10.1093/carcin/bgs189] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
282 Joo MS, Lee CG, Koo JH, Kim SG. miR-125b transcriptionally increased by Nrf2 inhibits AhR repressor, which protects kidney from cisplatin-induced injury. Cell Death Dis 2013;4:e899. [PMID: 24176857 DOI: 10.1038/cddis.2013.427] [Cited by in F6Publishing: 56] [Reference Citation Analysis]
283 He C, Danes JM, Hart PC, Zhu Y, Huang Y, de Abreu AL, O'Brien J, Mathison AJ, Tang B, Frasor JM, Wakefield LM, Ganini D, Stauder E, Zielonka J, Gantner BN, Urrutia RA, Gius D, Bonini MG. SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer. Proc Natl Acad Sci U S A 2019;116:23534-41. [PMID: 31591207 DOI: 10.1073/pnas.1902308116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
284 Škovierová H, Okajčeková T, Strnádel J, Vidomanová E, Halašová E. Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review). Int J Mol Med 2018;41:1187-200. [PMID: 29286071 DOI: 10.3892/ijmm.2017.3320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
285 Romero-pérez L, López-garcía MÁ, Díaz-martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-guiu X, Soslow RA, Palacios J. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma. Mod Pathol 2013;26:1514-24. [DOI: 10.1038/modpathol.2013.93] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
286 Bloehdorn J, Braun A, Taylor-Weiner A, Jebaraj BMC, Robrecht S, Krzykalla J, Pan H, Giza A, Akylzhanova G, Holzmann K, Scheffold A, Johnston HE, Yeh RF, Klymenko T, Tausch E, Eichhorst B, Bullinger L, Fischer K, Weisser M, Robak T, Schneider C, Gribben J, Dahal LN, Carter MJ, Elemento O, Landau DA, Neuberg DS, Cragg MS, Benner A, Hallek M, Wu CJ, Döhner H, Stilgenbauer S, Mertens D. Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat Commun 2021;12:5395. [PMID: 34518531 DOI: 10.1038/s41467-021-25403-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
287 Wang Z, Wu L, Tong S, Hu X, Zu X, Li Y, He W, Liu L, Chen M, Qi L. Resveratrol suppresses the epithelial-to-mesenchymal transition in PC-3 cells by down-regulating the PI3K/AKT signaling pathway. Animal Cells and Systems 2016;20:77-85. [DOI: 10.1080/19768354.2016.1150344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
288 Zhan P, Shu X, Chen M, Sun L, Yu L, Liu J, Sun L, Yang Z, Ran Y. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1. Life Sci 2021;276:119405. [PMID: 33798550 DOI: 10.1016/j.lfs.2021.119405] [Reference Citation Analysis]
289 Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21-45. [PMID: 27368099 DOI: 10.1016/j.cell.2016.06.028] [Cited by in Crossref: 1978] [Cited by in F6Publishing: 1921] [Article Influence: 395.6] [Reference Citation Analysis]
290 Ohtsuka J, Oshima H, Ezawa I, Abe R, Oshima M, Ohki R. Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers. Sci Rep 2018;8:2291. [PMID: 29396430 DOI: 10.1038/s41598-018-20572-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
291 Chen Y, Zhang L. WITHDRAWN: MiR-200 family and cancer: Function, regulation and signaling. Surg Oncol 2014:S0960-7404(14)00010-3. [PMID: 24679605 DOI: 10.1016/j.suronc.2014.03.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
292 Fridrichova I, Zmetakova I. MicroRNAs Contribute to Breast Cancer Invasiveness. Cells 2019;8:E1361. [PMID: 31683635 DOI: 10.3390/cells8111361] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
293 Hashimoto A, Hashimoto S, Sugino H, Yoshikawa A, Onodera Y, Handa H, Oikawa T, Sabe H. ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance. Oncogenesis 2016;5:e259. [PMID: 27617643 DOI: 10.1038/oncsis.2016.60] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
294 Chen PS, Su JL, Hung MC. Dysregulation of microRNAs in cancer. J Biomed Sci 2012;19:90. [PMID: 23075324 DOI: 10.1186/1423-0127-19-90] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 9.2] [Reference Citation Analysis]
295 Natsuizaka M, Whelan KA, Kagawa S, Tanaka K, Giroux V, Chandramouleeswaran PM, Long A, Sahu V, Darling DS, Que J, Yang Y, Katz JP, Wileyto EP, Basu D, Kita Y, Natsugoe S, Naganuma S, Klein-Szanto AJ, Diehl JA, Bass AJ, Wong KK, Rustgi AK, Nakagawa H. Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun 2017;8:1758. [PMID: 29170450 DOI: 10.1038/s41467-017-01500-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 13.6] [Reference Citation Analysis]
296 Marcel V, Catez F, Diaz J. p53, a translational regulator: contribution to its tumour-suppressor activity. Oncogene 2015;34:5513-23. [DOI: 10.1038/onc.2015.25] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
297 Ford NA, Dunlap SM, Wheatley KE, Hursting SD. Obesity, independent of p53 gene dosage, promotes mammary tumor progression and upregulates the p53 regulator microRNA-504. PLoS One 2013;8:e68089. [PMID: 23840816 DOI: 10.1371/journal.pone.0068089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
298 Huang S, Li XQ, Chen X, Che SM, Chen W, Zhang XZ. Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation. Dis Esophagus. 2013;26:823-831. [PMID: 22958183 DOI: 10.1111/j.1442-2050.2012.01389.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
299 Xiao Y, Yan W, Lu L, Wang Y, Lu W, Cao Y, Cai W. p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death. Cell Cycle 2015;14:1548-58. [PMID: 25789565 DOI: 10.1080/15384101.2015.1026491] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
300 Zada S, Hwang JS, Ahmed M, Lai TH, Pham TM, Elashkar O, Kim DR. Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy. Biochim Biophys Acta Rev Cancer 2021;1876:188565. [PMID: 33992723 DOI: 10.1016/j.bbcan.2021.188565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Dong P, Xiong Y, Yue J, Hanley SJB, Watari H. Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion. Front Oncol. 2018;8:386. [PMID: 30283733 DOI: 10.3389/fonc.2018.00386] [Cited by in Crossref: 77] [Cited by in F6Publishing: 89] [Article Influence: 19.3] [Reference Citation Analysis]
302 Mazurek M, Grochowski C, Litak J, Osuchowska I, Maciejewski R, Kamieniak P. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme. Int J Mol Sci 2020;21:E3046. [PMID: 32349263 DOI: 10.3390/ijms21093046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
303 Erturk E, Cecener G, Tezcan G, Egeli U, Tunca B, Gokgoz S, Tolunay S, Tasdelen I. BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer. Gene 2015;556:163-9. [PMID: 25445393 DOI: 10.1016/j.gene.2014.11.047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
304 Lu S, Cai C, Yan G, Zhou Z, Wan Y, Chen V, Chen L, Cooper GF, Obeid LM, Hannun YA, Lee AV, Lu X. Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations. Cancer Res 2016;76:6785-94. [PMID: 27758891 DOI: 10.1158/0008-5472.CAN-16-1740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
305 Mohammady M, Ghetmiri SI, Baharizade M, Morowvat MH, Torabi S. Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy. Curr Pharm Biotechnol 2019;20:665-73. [PMID: 31244419 DOI: 10.2174/1389201020666190617162042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Fazilaty H, Gardaneh M, Bahrami T, Salmaninejad A, Behnam B. Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway? Tumour Biol 2013;34:2019-30. [PMID: 23686802 DOI: 10.1007/s13277-013-0831-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
307 Roszkowska KA, Gizinski S, Sady M, Gajewski Z, Olszewski MB. Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis. Int J Mol Sci 2020;21:E1334. [PMID: 32079237 DOI: 10.3390/ijms21041334] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
308 Liu WH, Chang LS. Suppression of Akt/Foxp3-mediated miR-183 expression blocks Sp1-mediated ADAM17 expression and TNFα-mediated NFκB activation in piceatannol-treated human leukemia U937 cells. Biochem Pharmacol 2012;84:670-80. [PMID: 22705645 DOI: 10.1016/j.bcp.2012.06.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
309 McCubrey JA, Lertpiriyapong K, Fitzgerald TL, Martelli AM, Cocco L, Rakus D, Gizak A, Libra M, Cervello M, Montalto G, Yang LV, Abrams SL, Steelman LS. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis. Adv Biol Regul 2017;63:32-48. [PMID: 27776972 DOI: 10.1016/j.jbior.2016.10.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
310 Jansson MD, Damas ND, Lees M, Jacobsen A, Lund AH. miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2. Oncogene 2015;34:1908-18. [DOI: 10.1038/onc.2014.130] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
311 Wu Y, Sarkissyan M, Vadgama JV. Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med 2016;5:E13. [PMID: 26821054 DOI: 10.3390/jcm5020013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 17.2] [Reference Citation Analysis]
312 Mello SS, Attardi LD. Deciphering p53 signaling in tumor suppression. Curr Opin Cell Biol 2018;51:65-72. [PMID: 29195118 DOI: 10.1016/j.ceb.2017.11.005] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 19.8] [Reference Citation Analysis]
313 Chen HT, Liu H, Mao MJ, Tan Y, Mo XQ, Meng XJ, Cao MT, Zhong CY, Liu Y, Shan H, Jiang GM. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer 2019;18:101. [PMID: 31126310 DOI: 10.1186/s12943-019-1030-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 75] [Article Influence: 22.0] [Reference Citation Analysis]
314 Ramadoss S, Guo G, Wang CY. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. Oncogene 2017;36:47-59. [PMID: 27270439 DOI: 10.1038/onc.2016.174] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 9.0] [Reference Citation Analysis]
315 Zhu L, Lu Z, Zhao H. Antitumor mechanisms when pRb and p53 are genetically inactivated. Oncogene 2015;34:4547-57. [PMID: 25486431 DOI: 10.1038/onc.2014.399] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
316 Han H, Du Y, Zhao W, Li S, Chen D, Zhang J, Liu J, Suo Z, Bian X, Xing B, Zhang Z. PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells. Nat Commun. 2015;6:8271. [PMID: 26420065 DOI: 10.1038/ncomms9271] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
317 Shen Y, Wang P, Li Y, Ye F, Wang F, Wan X, Cheng X, Lu W, Xie X. miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. Br J Cancer 2013;109:92-9. [PMID: 23778521 DOI: 10.1038/bjc.2013.308] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
318 di Gennaro A, Damiano V, Brisotto G, Armellin M, Perin T, Zucchetto A, Guardascione M, Spaink HP, Doglioni C, Snaar-Jagalska BE, Santarosa M, Maestro R. A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness. Cell Death Differ 2018;25:2165-80. [PMID: 29666469 DOI: 10.1038/s41418-018-0103-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 11.3] [Reference Citation Analysis]
319 Granit RZ, Slyper M, Ben-Porath I. Axes of differentiation in breast cancer: untangling stemness, lineage identity, and the epithelial to mesenchymal transition. Wiley Interdiscip Rev Syst Biol Med 2014;6:93-106. [PMID: 24741710 DOI: 10.1002/wsbm.1252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
320 Shen YA, Pan SC, Chu I, Lai RY, Wei YH. Targeting cancer stem cells from a metabolic perspective. Exp Biol Med (Maywood) 2020;245:465-76. [PMID: 32102562 DOI: 10.1177/1535370220909309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
321 Tian B, Li X, Kalita M, Widen SG, Yang J, Bhavnani SK, Dang B, Kudlicki A, Sinha M, Kong F, Wood TG, Luxon BA, Brasier AR. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition. BMC Genomics 2015;16:529. [PMID: 26187636 DOI: 10.1186/s12864-015-1707-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
322 Kunc M, Gabrych A, Rekawiecki B, Gorczynski A, Franke S, Haybaeck J, Biernat W, Czapiewski P. MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation. Contemp Oncol (Pozn) 2019;23:202-7. [PMID: 31992951 DOI: 10.5114/wo.2019.89635] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
323 Pal A, Melling G, Hinsley EE, Kabir TD, Colley HE, Murdoch C, Lambert DW. Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145. J Oral Pathol Med 2013;42:309-14. [PMID: 23173553 DOI: 10.1111/jop.12017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
324 Al-khalaf HH, Aboussekhra A. p16 INK4A induces senescence and inhibits EMT through microRNA-141/microRNA-146b-5p-dependent repression of AUF1: p16 CONTROLS EMT AND SENESCENCE THROUGH miR-141 AND miR-146b-5p. Mol Carcinog 2017;56:985-99. [DOI: 10.1002/mc.22564] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
325 Joseph JV, Conroy S, Pavlov K, Sontakke P, Tomar T, Eggens-Meijer E, Balasubramaniyan V, Wagemakers M, den Dunnen WF, Kruyt FA. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Cancer Lett 2015;359:107-16. [PMID: 25592037 DOI: 10.1016/j.canlet.2015.01.010] [Cited by in Crossref: 155] [Cited by in F6Publishing: 151] [Article Influence: 22.1] [Reference Citation Analysis]
326 Denisenko TV, Pivnyuk AD, Zhivotovsky B. p53-Autophagy-Metastasis Link. Cancers (Basel). 2018;10. [PMID: 29783720 DOI: 10.3390/cancers10050148] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
327 Zhang R, Hardin H, Chen J, Guo Z, Lloyd RV. Non-Coding RNAs in Thyroid Cancer. Endocr Pathol 2016;27:12-20. [PMID: 26847830 DOI: 10.1007/s12022-016-9417-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
328 Lindner P, Paul S, Eckstein M, Hampel C, Muenzner JK, Erlenbach-Wuensch K, Ahmed HP, Mahadevan V, Brabletz T, Hartmann A, Vera J, Schneider-Stock R. EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells. Cell Death Dis 2020;11:147. [PMID: 32094334 DOI: 10.1038/s41419-020-2340-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
329 French R, Pauklin S. Epigenetic regulation of cancer stem cell formation and maintenance. Int J Cancer 2021;148:2884-97. [PMID: 33197277 DOI: 10.1002/ijc.33398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
330 Hara ES, Ono M, Eguchi T, Kubota S, Pham HT, Sonoyama W, Tajima S, Takigawa M, Calderwood SK, Kuboki T. miRNA-720 controls stem cell phenotype, proliferation and differentiation of human dental pulp cells. PLoS One 2013;8:e83545. [PMID: 24386225 DOI: 10.1371/journal.pone.0083545] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
331 Ghosh B, Leach SD. p53: Guardian of pancreatic epithelial identity. Cell Cycle 2011;10:1717. [PMID: 21597331 DOI: 10.4161/cc.10.11.15686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
332 Eldridge CB, Allen FJ, Crisp A, Grandy RA, Vallier L, Sale JE. A p53-Dependent Checkpoint Induced upon DNA Damage Alters Cell Fate during hiPSC Differentiation. Stem Cell Reports 2020;15:827-35. [PMID: 32888504 DOI: 10.1016/j.stemcr.2020.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
333 Cui J, Cheng Y, Zhang P, Sun M, Gao F, Liu C, Cai J. Down Regulation of miR200c Promotes Radiation-Induced Thymic Lymphoma by Targeting BMI1: THYMIC LYMPHOMA BY TARGETING BMI1. J Cell Biochem 2014;115:1033-42. [DOI: 10.1002/jcb.24754] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
334 Shin DY, Jeong MH, Bang IJ, Kim HR, Chung KH. MicroRNA regulatory networks reflective of polyhexamethylene guanidine phosphate-induced fibrosis in A549 human alveolar adenocarcinoma cells. Toxicol Lett 2018;287:49-58. [PMID: 29337256 DOI: 10.1016/j.toxlet.2018.01.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
335 Lee YJ, Park KS, Heo SH, Nam HS, Cho MK, Lee SH. Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial-mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis. Arch Pharm Res 2019;42:890-901. [PMID: 31428976 DOI: 10.1007/s12272-019-01181-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
336 Bornachea O, Santos M, Martínez-Cruz AB, García-Escudero R, Dueñas M, Costa C, Segrelles C, Lorz C, Buitrago A, Saiz-Ladera C, Agirre X, Grande T, Paradela B, Maraver A, Ariza JM, Prosper F, Serrano M, Sánchez-Céspedes M, Paramio JM. EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours. Sci Rep 2012;2:434. [PMID: 22666537 DOI: 10.1038/srep00434] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
337 Voutsadakis IA. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer. Tumour Biol. 2012;33:897-910. [PMID: 22399444 DOI: 10.1007/s13277-012-0355-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
338 Pustovalova M, Alhaddad L, Blokhina T, Smetanina N, Chigasova A, Chuprov-Netochin R, Eremin P, Gilmutdinova I, Osipov AN, Leonov S. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status. Int J Mol Sci 2021;22:2369. [PMID: 33673439 DOI: 10.3390/ijms22052369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Abbas HA, Bui NHB, Rajapakshe K, Wong J, Gunaratne P, Tsai KY, Coarfa C, Flores ER. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes. Cancer Res 2018;78:451-62. [PMID: 29180475 DOI: 10.1158/0008-5472.CAN-17-1803] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
340 Cai ZG, Zhang SM, Zhang H, Zhou YY, Wu HB, Xu XP. Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line. Cell Biol Int. 2013;37:669-674. [PMID: 23483606 DOI: 10.1002/cbin.10087] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
341 Shariat Razavi SM, Forghanifard MM, Kordi-Tamandani DM, Abbaszadegan MR. MAML1 regulates EMT markers expression through NOTCH-independent pathway in breast cancer cell line MCF7. Biochem Biophys Res Commun 2019;510:376-82. [PMID: 30732857 DOI: 10.1016/j.bbrc.2019.01.101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
342 Jia L, Zhang S, Ye Y, Li X, Mercado-Uribe I, Bast RC Jr, Liu J. Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells. Cancer Lett 2012;326:176-82. [PMID: 22902993 DOI: 10.1016/j.canlet.2012.08.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
343 Lee Y, Kim J, Lee J, Lee JHJ, Sahu S, Kwon H, Park S, Jang S, Lee J, Wang Z, Tam WL, Lim B, Kang N, Chang Y. Identification of Tumor Initiating Cells with a Small-Molecule Fluorescent Probe by Using Vimentin as a Biomarker. Angew Chem Int Ed 2018;57:2851-4. [DOI: 10.1002/anie.201712920] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
344 Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B. The p63 protein isoform δnp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of mir-205. J BiolChem. 2013;288:3275-3288. [PMID: 23239884 DOI: 10.1074/jbc.m112.408104] [Cited by in Crossref: 93] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
345 Jones R, Watson K, Bruce A, Nersesian S, Kitz J, Moorehead R. Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells. Oncotarget 2017;8:23727-49. [PMID: 28423599 DOI: 10.18632/oncotarget.15829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
346 Hamilton G, Rath B. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer. In: Magbanua MJM, Park JW, editors. Isolation and Molecular Characterization of Circulating Tumor Cells. Cham: Springer International Publishing; 2017. pp. 229-45. [DOI: 10.1007/978-3-319-55947-6_12] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
347 Ni T, Li XY, Lu N, An T, Liu ZP, Fu R, Lv WC, Zhang YW, Xu XJ, Grant Rowe R, Lin YS, Scherer A, Feinberg T, Zheng XQ, Chen BA, Liu XS, Guo QL, Wu ZQ, Weiss SJ. Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer. Nat Cell Biol 2016;18:1221-32. [PMID: 27749822 DOI: 10.1038/ncb3425] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 9.2] [Reference Citation Analysis]
348 Bose B, Sen U, Shenoy P S. Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives. J Cell Biochem 2018;119:141-9. [PMID: 28590064 DOI: 10.1002/jcb.26196] [Reference Citation Analysis]
349 Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer. World J Gastroenterol 2013; 19(18): 2781-2792 [PMID: 23687415 DOI: 10.3748/wjg.v19.i18.2781] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
350 Mathieu J, Ruohola-Baker H. Regulation of stem cell populations by microRNAs. Adv Exp Med Biol. 2013;786:329-351. [PMID: 23696365 DOI: 10.1007/978-94-007-6621-1_18] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 9.2] [Reference Citation Analysis]
351 Zeng K, Chen X, Hu X, Liu X, Xu T, Sun H, Pan Y, He B, Wang S. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Oncogene 2018;37:5534-51. [PMID: 29899406 DOI: 10.1038/s41388-018-0352-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
352 Bullock MD, Sayan AE, Packham GK, Mirnezami AH. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biology of the Cell 2012;104:3-12. [DOI: 10.1111/boc.201100115] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 9.2] [Reference Citation Analysis]
353 Sun Y, Guo F, Bagnoli M, Xue FX, Sun BC, Shmulevich I, Mezzanzanica D, Chen KX, Sood AK, Yang D, Zhang W. Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer. Chin J Cancer 2015;34:28-40. [PMID: 25556616 DOI: 10.5732/cjc.014.10284] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
354 Ye J, Wei X, Shang Y, Pan Q, Yang M, Tian Y, He Y, Peng Z, Chen L, Chen W, Wang R. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity. Oncogene 2017;36:6391-407. [PMID: 28745318 DOI: 10.1038/onc.2017.241] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
355 Lu Z, Jiao D, Qiao J, Yang S, Yan M, Cui S, Liu Z. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73. Mol Cancer 2015;14:102. [PMID: 25972084 DOI: 10.1186/s12943-015-0370-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
356 Xie G, Ji A, Yuan Q, Jin Z, Yuan Y, Ren C, Guo Z, Yao Q, Yang K, Lin X, Chen L. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines. Br J Cancer 2014;110:2514-23. [PMID: 24755887 DOI: 10.1038/bjc.2014.153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
357 Jones M, Lal A. MicroRNAs, wild-type and mutant p53: more questions than answers. RNA Biol 2012;9:781-91. [PMID: 22664917 DOI: 10.4161/rna.20146] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
358 Hinton A, Hunter S, Reyes G, Fogel GB, King CC. From pluripotency to islets: miRNAs as critical regulators of human cellular differentiation. Adv Genet 2012;79:1-34. [PMID: 22989764 DOI: 10.1016/B978-0-12-394395-8.00001-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
359 Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang Y, Li J, Zhao Z. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells. Int J Cancer 2014;135:1019-27. [PMID: 24500893 DOI: 10.1002/ijc.28761] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
360 Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med 2018;12:361-73. [PMID: 30043221 DOI: 10.1007/s11684-018-0656-6] [Cited by in Crossref: 176] [Cited by in F6Publishing: 175] [Article Influence: 44.0] [Reference Citation Analysis]
361 Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol. 2011;195:417-433. [PMID: 22024162 DOI: 10.1083/jcb.201103097] [Cited by in Crossref: 296] [Cited by in F6Publishing: 285] [Article Influence: 26.9] [Reference Citation Analysis]
362 Pádua Alves C, Fonseca AS, Muys BR, de Barros E Lima Bueno R, Bürger MC, de Souza JE, Valente V, Zago MA, Silva WA. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells. 2013;31:2827-2832. [PMID: 24022994 DOI: 10.1002/stem.1547] [Cited by in Crossref: 148] [Cited by in F6Publishing: 153] [Article Influence: 21.1] [Reference Citation Analysis]
363 Li X, Wu Z, Fu X, Han W. Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases. Med Res Rev. 2013;33:517-553. [PMID: 22318902 DOI: 10.1002/med.21254] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 10.0] [Reference Citation Analysis]
364 Chen J, Wang G, Lu C, Guo X, Hong W, Kang J, Wang J. Synergetic cooperation of microRNAs with transcription factors in iPS cell generation. PLoS One 2012;7:e40849. [PMID: 22808276 DOI: 10.1371/journal.pone.0040849] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
365 von Brandenstein M, Schlosser M, Herden J, Heidenreich A, Störkel S, Fries JWU. MicroRNAs as Urinary Biomarker for Oncocytoma. Dis Markers 2018;2018:6979073. [PMID: 30116406 DOI: 10.1155/2018/6979073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
366 Groza IM, Braicu C, Jurj A, Zanoaga O, Lajos R, Chiroi P, Cojocneanu R, Paun D, Irimie A, Korban SS, Achimas-Cadariu P, Berindan-Neagoe I. Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic. Cancers (Basel) 2020;12:E3053. [PMID: 33092068 DOI: 10.3390/cancers12103053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
367 Hill L, Browne G, Tulchinsky E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013;132:745-754. [PMID: 22753312 DOI: 10.1002/ijc.27708] [Cited by in Crossref: 154] [Cited by in F6Publishing: 153] [Article Influence: 15.4] [Reference Citation Analysis]
368 Aloni-Grinstein R, Shetzer Y, Kaufman T, Rotter V. p53: the barrier to cancer stem cell formation. FEBS Lett 2014;588:2580-9. [PMID: 24560790 DOI: 10.1016/j.febslet.2014.02.011] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
369 Liu W, Zhou X, Xing D. Rapid and reliable microRNA detection by stacking hybridization on electrochemiluminescent chip system. Biosens Bioelectron 2014;58:388-94. [PMID: 24705177 DOI: 10.1016/j.bios.2014.02.082] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
370 Mekala JR, Naushad SM, Ponnusamy L, Arivazhagan G, Sakthiprasad V, Pal-Bhadra M. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer. Gene 2018;641:248-58. [PMID: 29038000 DOI: 10.1016/j.gene.2017.10.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
371 Fabregat I, Malfettone A, Soukupova J. New Insights into the Crossroads between EMT and Stemness in the Context of Cancer. J Clin Med 2016;5:E37. [PMID: 26985909 DOI: 10.3390/jcm5030037] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 13.0] [Reference Citation Analysis]
372 Cursons J, Leuchowius KJ, Waltham M, Tomaskovic-Crook E, Foroutan M, Bracken CP, Redfern A, Crampin EJ, Street I, Davis MJ, Thompson EW. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines. Cell Commun Signal 2015;13:26. [PMID: 25975820 DOI: 10.1186/s12964-015-0106-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
373 Wang Y, Ryu HS, Jang JJ. Nicotinamide suppresses cell growth by G1-phase arrest and induces apoptosis in intrahepatic cholangiocarcinoma. Mol Cell Toxicol 2018;14:43-51. [DOI: 10.1007/s13273-018-0006-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
374 Mai L, Yi F, Gou X, Zhang J, Wang C, Liu G, Bu Y, Yuan C, Deng L, Song F. The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer. Mol Cell Biochem 2014;392:95-107. [PMID: 24633962 DOI: 10.1007/s11010-014-2022-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
375 Mukhopadhyay U, Banerjee A, Chawla-Sarkar M, Mukherjee A. Rotavirus Induces Epithelial-Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b. Front Microbiol 2021;12:631183. [PMID: 33679655 DOI: 10.3389/fmicb.2021.631183] [Reference Citation Analysis]
376 Pacurari M, Addison JB, Bondalapati N, Wan YW, Luo D, Qian Y, Castranova V, Ivanov AV, Guo NL. The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells. Int J Oncol 2013;43:548-60. [PMID: 23708087 DOI: 10.3892/ijo.2013.1963] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
377 Manna A, Banerjee S, Khan P, Bhattacharya A, Das T. Contribution of nuclear events in generation and maintenance of cancer stem cells: revisiting chemo-resistance. Nucleus 2017;60:121-35. [DOI: 10.1007/s13237-017-0193-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
378 Carrà G, Lingua MF, Maffeo B, Taulli R, Morotti A. P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa. Cell Mol Life Sci 2020;77:4449-58. [DOI: 10.1007/s00018-020-03524-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
379 Shah MS, Davidson LA, Chapkin RS. Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. Front Genet 2012;3:305. [PMID: 23293655 DOI: 10.3389/fgene.2012.00305] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
380 Decker JT, Hall MS, Blaisdell RB, Schwark K, Jeruss JS, Shea LD. Dynamic microRNA activity identifies therapeutic targets in trastuzumab-resistant HER2+ breast cancer. Biotechnol Bioeng 2018;115:2613-23. [PMID: 29981261 DOI: 10.1002/bit.26791] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
381 Chen J, Zhong Y, Li L. miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC). J Transl Med 2020;18:69. [PMID: 32046742 DOI: 10.1186/s12967-020-02242-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
382 Babaei G, Aliarab A, Asghari Vostakolaei M, Hotelchi M, Neisari R, Gholizadeh-Ghaleh Aziz S, Bazl MR. Crosslink between p53 and metastasis: focus on epithelial-mesenchymal transition, cancer stem cell, angiogenesis, autophagy, and anoikis. Mol Biol Rep 2021;48:7545-57. [PMID: 34519942 DOI: 10.1007/s11033-021-06706-1] [Reference Citation Analysis]
383 Kaiser AM, Attardi LD. Deconstructing networks of p53-mediated tumor suppression in vivo. Cell Death Differ 2018;25:93-103. [PMID: 29099489 DOI: 10.1038/cdd.2017.171] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 19.2] [Reference Citation Analysis]
384 Ali Hosseini Rad SM, Bavarsad MS, Arefian E, Jaseb K, Shahjahani M, Saki N. The Role of microRNAs in Stemness of Cancer Stem Cells. Oncol Rev 2013;7:e8. [PMID: 25992229 DOI: 10.4081/oncol.2013.e8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
385 Muñoz P, Iliou MS, Esteller M. Epigenetic alterations involved in cancer stem cell reprogramming. Mol Oncol 2012;6:620-36. [PMID: 23141800 DOI: 10.1016/j.molonc.2012.10.006] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 11.8] [Reference Citation Analysis]
386 Duband JL, Dady A, Fleury V. Resolving time and space constraints during neural crest formation and delamination. Curr Top Dev Biol 2015;111:27-67. [PMID: 25662257 DOI: 10.1016/bs.ctdb.2014.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
387 Ding B, Gao H, Song J, Li Y, Zhang L, Cao X, Xu M, Cai J. Tough and Cell-Compatible Chitosan Physical Hydrogels for Mouse Bone Mesenchymal Stem Cells in Vitro. ACS Appl Mater Interfaces 2016;8:19739-46. [DOI: 10.1021/acsami.6b05302] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
388 Liang Y, Besch-Williford C, Cook MT, Belenchia A, Brekken RA, Hyder SM. APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice. Breast Cancer (Dove Med Press) 2019;11:249-59. [PMID: 31534364 DOI: 10.2147/BCTT.S208706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
389 Kong X, Ding X, Li X, Gao S, Yang Q. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Cancer Sci 2015;106:982-9. [PMID: 26011542 DOI: 10.1111/cas.12699] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
390 Ye X, Jiang F, Li Y, Mu J, Si L, Wang X, Ning S, Li Z. Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c. Cancer Sci 2014;105:875-82. [PMID: 24754877 DOI: 10.1111/cas.12426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
391 O'brien SJ, Carter JV, Burton JF, Oxford BG, Schmidt MN, Hallion JC, Galandiuk S. The role of the miR-200 family in epithelial-mesenchymal transition in colorectal cancer: a systematic review: Role of miR-200 family in EMT in colorectal cancer. Int J Cancer 2018;142:2501-11. [DOI: 10.1002/ijc.31282] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
392 Dunphy KA, Seo JH, Kim DJ, Roberts AL, Tao L, DiRenzo J, Balboni AL, Crisi GM, Hagen MJ, Chandrasekaran T, Gauger KJ, Schneider SS, Jerry DJ. Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation. Cancer Cell Int 2013;13:74. [PMID: 23883065 DOI: 10.1186/1475-2867-13-74] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
393 Voon DC, Wang H, Koo JK, Nguyen TA, Hor YT, Chu YS, Ito K, Fukamachi H, Chan SL, Thiery JP. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity. Stem Cells. 2012;30:2088-2099. [PMID: 22899304 DOI: 10.1002/stem.1183] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
394 Wang SS, Jiang J, Liang XH, Tang YL. Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther 2015;8:2973-80. [PMID: 26527883 DOI: 10.2147/OTT.S91863] [Cited by in Crossref: 19] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
395 Heinrich EL, Walser TC, Krysan K, Liclican EL, Grant JL, Rodriguez NL, Dubinett SM. The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron 2012;5:5-18. [PMID: 21922183 DOI: 10.1007/s12307-011-0089-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
396 Knouf EC, Garg K, Arroyo JD, Correa Y, Sarkar D, Parkin RK, Wurz K, O'Briant KC, Godwin AK, Urban ND, Ruzzo WL, Gentleman R, Drescher CW, Swisher EM, Tewari M. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res 2012;40:499-510. [PMID: 21917857 DOI: 10.1093/nar/gkr731] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
397 van Heemst D. Variation in DNA damage response pathway activity: focus on intermediate phenotype instead of genetic polymorphisms. Cell Cycle 2011;10:1714. [PMID: 21537112 DOI: 10.4161/cc.10.11.15592] [Reference Citation Analysis]
398 Janaki Ramaiah M, Divyapriya K, Kartik Kumar S, Rajesh YBRD. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme. Gene 2020;723:144126. [PMID: 31589963 DOI: 10.1016/j.gene.2019.144126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
399 Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 2016;7:12632. [PMID: 27572267 DOI: 10.1038/ncomms12632] [Cited by in Crossref: 292] [Cited by in F6Publishing: 313] [Article Influence: 48.7] [Reference Citation Analysis]
400 Zhu GJ, Song PP, Zhou H, Shen XH, Wang JG, Ma XF, Gu YJ, Liu DD, Feng AN, Qian XY, Gao X. Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma. Oncol Lett 2018;15:3472-81. [PMID: 29467869 DOI: 10.3892/ol.2018.7751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
401 Wu CY, Tsai YP, Wu MZ, Teng SC, Wu KJ. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet 2012;28:454-63. [PMID: 22717049 DOI: 10.1016/j.tig.2012.05.005] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 10.9] [Reference Citation Analysis]
402 Kim HJ, Eoh KJ, Kim LK, Nam EJ, Yoon SO, Kim KH, Lee JK, Kim SW, Kim YT. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer. Oncotarget. 2016;7:83001-83016. [PMID: 27792998 DOI: 10.18632/oncotarget.12863] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
403 DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ, DiRenzo J. MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition. Cell Death Dis 2013;4:e514. [PMID: 23449450 DOI: 10.1038/cddis.2013.37] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
404 Forte E, Chimenti I, Rosa P, Angelini F, Pagano F, Calogero A, Giacomello A, Messina E. EMT/MET at the Crossroad of Stemness, Regeneration and Oncogenesis: The Ying-Yang Equilibrium Recapitulated in Cell Spheroids. Cancers (Basel) 2017;9:E98. [PMID: 28758926 DOI: 10.3390/cancers9080098] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 7.4] [Reference Citation Analysis]
405 Puisieux A, Brabletz T, Caramel J. Oncogenic roles of EMT-inducing transcription factors. Nat Cell Biol. 2014;16:488-494. [PMID: 24875735 DOI: 10.1038/ncb2976] [Cited by in Crossref: 532] [Cited by in F6Publishing: 527] [Article Influence: 66.5] [Reference Citation Analysis]
406 von Brandenstein M, Richter C, Fries JW. MicroRNAs: Small but amazing, and their association with endothelin. Life Sci 2012;91:475-89. [PMID: 22771694 DOI: 10.1016/j.lfs.2012.06.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
407 Drake LE, Macleod KF. Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again? J Pathol 2014;232:283-8. [PMID: 24254977 DOI: 10.1002/path.4298] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
408 Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012;12:613-26. [DOI: 10.1038/nrc3318] [Cited by in Crossref: 344] [Cited by in F6Publishing: 345] [Article Influence: 34.4] [Reference Citation Analysis]
409 Sui X, Zhu J, Tang H, Wang C, Zhou J, Han W, Wang X, Fang Y, Xu Y, Li D, Chen R, Ma J, Jing Z, Gu X, Pan H, He C. p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin. Oncotarget 2015;6:22869-79. [PMID: 26362504 DOI: 10.18632/oncotarget.5137] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
410 Wang E, Li Y, Ming R, Wei J, Du P, Zhou P, Zong S, Xiao H. The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:718974. [PMID: 34917609 DOI: 10.3389/fcell.2021.718974] [Reference Citation Analysis]
411 Shen YA, Lin CH, Chi WH, Wang CY, Hsieh YT, Wei YH, Chen YJ. Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation. Evid Based Complement Alternat Med. 2013;2013:590393. [PMID: 23737838 DOI: 10.1155/2013/590393] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
412 Xiong H, Li Q, Chen R, Liu S, Lin Q, Xiong Z, Jiang Q, Guo L. A Multi-Step miRNA-mRNA Regulatory Network Construction Approach Identifies Gene Signatures Associated with Endometrioid Endometrial Carcinoma. Genes (Basel) 2016;7:E26. [PMID: 27271671 DOI: 10.3390/genes7060026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
413 Oikawa T, Otsuka Y, Sabe H. p53-Dependent and -Independent Epithelial Integrity: Beyond miRNAs and Metabolic Fluctuations. Cancers (Basel) 2018;10:E162. [PMID: 29799511 DOI: 10.3390/cancers10060162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
414 Mutlu M, Raza U, Saatci Ö, Eyüpoğlu E, Yurdusev E, Şahin Ö. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. J Mol Med (Berl) 2016;94:629-44. [PMID: 27094812 DOI: 10.1007/s00109-016-1420-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 12.8] [Reference Citation Analysis]
415 Mooney SM, Talebian V, Jolly MK, Jia D, Gromala M, Levine H, McConkey BJ. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer. J Cell Biochem 2017;118:2559-70. [PMID: 28266048 DOI: 10.1002/jcb.25974] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 11.4] [Reference Citation Analysis]
416 Singh R, Mo YY. Role of microRNAs in breast cancer. Cancer Biol Ther. 2013;14:201-212. [PMID: 23291983 DOI: 10.4161/cbt.23296] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 8.1] [Reference Citation Analysis]
417 Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther 2016;1:15004. [PMID: 29263891 DOI: 10.1038/sigtrans.2015.4] [Cited by in Crossref: 749] [Cited by in F6Publishing: 749] [Article Influence: 124.8] [Reference Citation Analysis]
418 Zhang J, Lei Y, Gao X, Liang Q, Li L, Feng J, Hou P, Han L, Zhang Y, Huang B, Lu J. p53 Attenuates the oncogenic Ras-induced epithelial-mesenchymal transition in human mammary epithelial cells. Biochem Biophys Res Commun 2013;434:606-13. [PMID: 23583409 DOI: 10.1016/j.bbrc.2013.03.124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
419 Majc B, Sever T, Zarić M, Breznik B, Turk B, Lah TT. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment. Biochim Biophys Acta Mol Cell Res 2020;1867:118782. [PMID: 32554164 DOI: 10.1016/j.bbamcr.2020.118782] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
420 Chu R, Mo G, Duan Z, Huang M, Chang J, Li X, Liu P. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Cell Commun Signal. 2014;12:45. [PMID: 25012758 DOI: 10.1186/s12964-014-0045-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
421 Franceschi T, Durieux E, Morel AP, de Saint Hilaire P, Ray-coquard I, Puisieux A, Devouassoux-shisheboran M. Role of epithelial–mesenchymal transition factors in the histogenesis of uterine carcinomas. Virchows Arch 2019;475:85-94. [DOI: 10.1007/s00428-019-02532-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
422 Zhou S, Zhang M, Zhou C, Wang W, Yang H, Ye W. The role of epithelial-mesenchymal transition in regulating radioresistance. Crit Rev Oncol Hematol 2020;150:102961. [PMID: 32361589 DOI: 10.1016/j.critrevonc.2020.102961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
423 Oikawa T, Otsuka Y, Onodera Y, Horikawa M, Handa H, Hashimoto S, Suzuki Y, Sabe H. Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity. Sci Rep 2018;8:1595. [PMID: 29371630 DOI: 10.1038/s41598-018-20043-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
424 Singh SK, Chen NM, Hessmann E, Siveke J, Lahmann M, Singh G, Voelker N, Vogt S, Esposito I, Schmidt A, Brendel C, Stiewe T, Gaedcke J, Mernberger M, Crawford HC, Bamlet WR, Zhang JS, Li XK, Smyrk TC, Billadeau DD, Hebrok M, Neesse A, Koenig A, Ellenrieder V. Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity. EMBO J 2015;34:517-30. [PMID: 25586376 DOI: 10.15252/embj.201489574] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
425 Li Y, Wang T, Sun Y, Huang T, Li C, Fu Y, Li Y, Li C. p53-Mediated PI3K/AKT/mTOR Pathway Played a Role in PtoxDpt-Induced EMT Inhibition in Liver Cancer Cell Lines. Oxid Med Cell Longev 2019;2019:2531493. [PMID: 31191795 DOI: 10.1155/2019/2531493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
426 Zhang B, Zhang Z, Xia S, Xing C, Ci X, Li X, Zhao R, Tian S, Ma G, Zhu Z, Fu L, Dong JT. KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells. Mol Cell Biol 2013;33:4919-35. [PMID: 24126055 DOI: 10.1128/MCB.00787-13] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
427 Yan H, Li Q, Wu J, Hu W, Jiang J, Shi L, Yang X, Zhu D, Ji M, Wu C. MiR-629 promotes human pancreatic cancer progression by targeting FOXO3. Cell Death Dis 2017;8:e3154. [PMID: 29072689 DOI: 10.1038/cddis.2017.525] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
428 Wang X, Wang C, Zhang X, Hua R, Gan L, Huang M, Zhao L, Ni S, Guo W. Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs. J Hematol Oncol 2016;9:90. [PMID: 27644439 DOI: 10.1186/s13045-016-0323-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
429 Chen KY, Chen CC, Chang YC, Chang MC. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9. PLoS One 2019;14:e0219317. [PMID: 31310624 DOI: 10.1371/journal.pone.0219317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
430 Soond SM, Kozhevnikova MV, Townsend PA, Zamyatnin AA Jr. Integrative p53, micro-RNA and Cathepsin Protease Co-Regulatory Expression Networks in Cancer. Cancers (Basel) 2020;12:E3454. [PMID: 33233599 DOI: 10.3390/cancers12113454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
431 Brabletz T. To differentiate or not--routes towards metastasis. Nat Rev Cancer. 2012;12:425-436. [PMID: 22576165 DOI: 10.1038/nrc3265] [Cited by in Crossref: 402] [Cited by in F6Publishing: 387] [Article Influence: 40.2] [Reference Citation Analysis]
432 Ghatak D, Das Ghosh D, Roychoudhury S. Cancer Stemness: p53 at the Wheel. Front Oncol 2020;10:604124. [PMID: 33505918 DOI: 10.3389/fonc.2020.604124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
433 Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med. 2011;18:74-82. [PMID: 22157681 DOI: 10.1038/nm.2577] [Cited by in Crossref: 260] [Cited by in F6Publishing: 270] [Article Influence: 23.6] [Reference Citation Analysis]
434 Li Y, Zhang MC, Xu XK, Zhao Y, Mahanand C, Zhu T, Deng H, Nevo E, Du JZ, Chen XQ. Functional Diversity of p53 in Human and Wild Animals. Front Endocrinol (Lausanne) 2019;10:152. [PMID: 30915036 DOI: 10.3389/fendo.2019.00152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
435 Markopoulos GS, Roupakia E, Tokamani M, Chavdoula E, Hatziapostolou M, Polytarchou C, Marcu KB, Papavassiliou AG, Sandaltzopoulos R, Kolettas E. A step-by-step microRNA guide to cancer development and metastasis. Cell Oncol 2017;40:303-39. [DOI: 10.1007/s13402-017-0341-9] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 16.8] [Reference Citation Analysis]
436 Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL, Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, Chang YC, Wang MY, Li CW, Shen J, Chen MK, Sahin AA, Sood A, Mills GB, Yu D, Hortobagyi GN, Hung MC. Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. Cancer Res 2014;74:4822-35. [PMID: 24970481 DOI: 10.1158/0008-5472.CAN-14-0584] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
437 Pereira L, Mariadason JM, Hannan RD, Dhillon AS. Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer. Front Oncol 2015;5:13. [PMID: 25699236 DOI: 10.3389/fonc.2015.00013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
438 Kai K, Iwamoto T, Zhang D, Shen L, Takahashi Y, Rao A, Thompson A, Sen S, Ueno NT. CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer. Sci Rep 2018;8:9427. [PMID: 29930294 DOI: 10.1038/s41598-018-27409-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
439 Kaller M, Hermeking H. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer. In: Slaby O, Calin GA, editors. Non-coding RNAs in Colorectal Cancer. Cham: Springer International Publishing; 2016. pp. 71-92. [DOI: 10.1007/978-3-319-42059-2_4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
440 Chang BP, Wang DS, Xing JW, Yang SH, Chu Q, Yu SY. miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1. J Huazhong Univ Sci Technolog Med Sci 2014;34:201-6. [PMID: 24710933 DOI: 10.1007/s11596-014-1259-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
441 Luo M, Wang F, Zhang H, To KKW, Wu S, Chen Z, Liang S, Fu L. Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer. Signal Transduct Target Ther 2020;5:141. [PMID: 32855386 DOI: 10.1038/s41392-020-0200-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
442 Braicu C, Zanoaga O, Zimta AA, Tigu AB, Kilpatrick KL, Bishayee A, Nabavi SM, Berindan-Neagoe I. Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells. Semin Cancer Biol 2020:S1044-579X(20)30111-5. [PMID: 32502598 DOI: 10.1016/j.semcancer.2020.05.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
443 Handa H, Hashimoto A, Hashimoto S, Sugino H, Oikawa T, Sabe H. Epithelial-specific histone modification of the miR-96/182 locus targeting AMAP1 mRNA predisposes p53 to suppress cell invasion in epithelial cells. Cell Commun Signal 2018;16:94. [PMID: 30509302 DOI: 10.1186/s12964-018-0302-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
444 Bertero T, Rezzonico R, Pottier N, Mari B. Impact of MicroRNAs in the Cellular Response to Hypoxia. Int Rev Cell Mol Biol 2017;333:91-158. [PMID: 28729029 DOI: 10.1016/bs.ircmb.2017.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
445 Hindley CJ, Condurat AL, Menon V, Thomas R, Azmitia LM, Davis JA, Pruszak J. The Hippo pathway member YAP enhances human neural crest cell fate and migration. Sci Rep 2016;6:23208. [PMID: 26980066 DOI: 10.1038/srep23208] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 9.3] [Reference Citation Analysis]
446 Najafi M, Mortezaee K, Ahadi R. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance. Life Sciences 2019;231:116520. [DOI: 10.1016/j.lfs.2019.05.076] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 13.3] [Reference Citation Analysis]
447 Hao Q, Wang J, Chen Y, Wang S, Cao M, Lu H, Zhou X. Dual regulation of p53 by the ribosome maturation factor SBDS. Cell Death Dis 2020;11:197. [PMID: 32198344 DOI: 10.1038/s41419-020-2393-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
448 Shore AN, Herschkowitz JI, Rosen JM. Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia 2012;17:43-58. [PMID: 22402938 DOI: 10.1007/s10911-012-9247-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
449 Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6:590-610. [PMID: 23102669 DOI: 10.1016/j.molonc.2012.09.006.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
450 Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen L, Chen H, Liu J. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3. J Transl Med 2014;12:305. [PMID: 25367080 DOI: 10.1186/s12967-014-0305-z] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 8.8] [Reference Citation Analysis]
451 Mestdagh P, Lefever S, Pattyn F, Ridzon D, Fredlund E, Fieuw A, Ongenaert M, Vermeulen J, De Paepe A, Wong L, Speleman F, Chen C, Vandesompele J. The microRNA body map: dissecting microRNA function through integrative genomics. Nucleic Acids Res 2011;39:e136. [PMID: 21835775 DOI: 10.1093/nar/gkr646] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
452 Tu L, Zhao E, Zhao W, Zhang Z, Tang D, Zhang Y, Wang C, Zhuang C, Cao H. hsa-miR-376c-3p Regulates Gastric Tumor Growth Both In Vitro and In Vivo. Biomed Res Int 2016;2016:9604257. [PMID: 27965982 DOI: 10.1155/2016/9604257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
453 Kolesnikoff N, Attema JL, Roslan S, Bert AG, Schwarz QP, Gregory PA, Goodall GJ. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition. J Biol Chem 2014;289:11194-205. [PMID: 24627491 DOI: 10.1074/jbc.M113.529172] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
454 Bertheau P, Lehmann-che J, Varna M, Dumay A, Poirot B, Porcher R, Turpin E, Plassa L, de Roquancourt A, Bourstyn E, de Cremoux P, Janin A, Giacchetti S, Espié M, de Thé H. p53 in breast cancer subtypes and new insights into response to chemotherapy. The Breast 2013;22:S27-9. [DOI: 10.1016/j.breast.2013.07.005] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 11.7] [Reference Citation Analysis]
455 Mayor R, Theveneau E. The neural crest. Development 2013;140:2247-51. [PMID: 23674598 DOI: 10.1242/dev.091751] [Cited by in Crossref: 194] [Cited by in F6Publishing: 175] [Article Influence: 21.6] [Reference Citation Analysis]
456 Slepicka PF, Somasundara AVH, dos Santos CO. The molecular basis of mammary gland development and epithelial differentiation. Seminars in Cell & Developmental Biology 2021;114:93-112. [DOI: 10.1016/j.semcdb.2020.09.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
457 Jones RA, Moorehead RA. Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence. Genes Chromosomes Cancer 2019;58:381-91. [PMID: 30597648 DOI: 10.1002/gcc.22729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
458 Jia D, Jolly MK, Tripathi SC, Den Hollander P, Huang B, Lu M, Celiktas M, Ramirez-Peña E, Ben-Jacob E, Onuchic JN, Hanash SM, Mani SA, Levine H. Distinguishing mechanisms underlying EMT tristability. Cancer Converg 2017;1:2. [PMID: 29623961 DOI: 10.1186/s41236-017-0005-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
459 Zeng W, Jiang S, Kong X, El-Ali N, Ball AR Jr, Ma CI, Hashimoto N, Yokomori K, Mortazavi A. Single-nucleus RNA-seq of differentiating human myoblasts reveals the extent of fate heterogeneity. Nucleic Acids Res 2016;44:e158. [PMID: 27566152 DOI: 10.1093/nar/gkw739] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
460 Gurzu S, Turdean S, Kovecsi A, Contac AO, Jung I. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update. World J Clin Cases 2015; 3(5): 393-404 [PMID: 25984514 DOI: 10.12998/wjcc.v3.i5.393] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
461 Floor SL, Dumont JE, Maenhaut C, Raspe E. Hallmarks of cancer: of all cancer cells, all the time? Trends Mol Med 2012;18:509-15. [PMID: 22795735 DOI: 10.1016/j.molmed.2012.06.005] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 8.1] [Reference Citation Analysis]
462 Boutelle AM, Attardi LD. p53 and Tumor Suppression: It Takes a Network. Trends Cell Biol 2021;31:298-310. [PMID: 33518400 DOI: 10.1016/j.tcb.2020.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
463 Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review. Pathol Res Pract. 2015;211:557-569. [PMID: 26092594 DOI: 10.1016/j.prp.2015.05.010] [Cited by in Crossref: 164] [Cited by in F6Publishing: 177] [Article Influence: 23.4] [Reference Citation Analysis]
464 Wadhwa R, Nigam N, Bhargava P, Dhanjal JK, Goyal S, Grover A, Sundar D, Ishida Y, Terao K, Kaul SC. Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin. J Cancer 2016;7:1755-71. [PMID: 27698914 DOI: 10.7150/jca.15170] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
465 Qiu M, Liang Z, Chen L, Tan G, Wang K, Liu L, Liu J, Chen H. MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma. Urol Oncol 2015;33:332.e9-18. [PMID: 25953723 DOI: 10.1016/j.urolonc.2015.03.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
466 Kato M, Park JT, Natarajan R. MicroRNAs and the glomerulus. Exp Cell Res 2012;318:993-1000. [PMID: 22421514 DOI: 10.1016/j.yexcr.2012.02.034] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
467 Liu Z, Chen L, Zhang X, Xu X, Xing H, Zhang Y, Li W, Yu H, Zeng J, Jia J. RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells. J Cell Mol Med 2014;18:610-23. [PMID: 24447545 DOI: 10.1111/jcmm.12209] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
468 Chung WC, Zhang S, Challagundla L, Zhou Y, Xu K. Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer. Neoplasia 2017;19:885-95. [PMID: 28938159 DOI: 10.1016/j.neo.2017.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
469 Cavallari I, Ciccarese F, Sharova E, Urso L, Raimondi V, Silic-Benussi M, D'Agostino DM, Ciminale V. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers (Basel) 2021;13:5874. [PMID: 34884985 DOI: 10.3390/cancers13235874] [Reference Citation Analysis]
470 Bogachek MV, De Andrade JP, Weigel RJ. Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors. Cancer Res 2015;75:11-5. [PMID: 25524900 DOI: 10.1158/0008-5472.CAN-14-2824] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
471 Bornachea O, López-Calderón FF, Dueñas M, Segrelles C, Lorz C, Suárez-Cabrera C, Marañón M, Paradela-Dobarro B, Santos M, Paramio JM. The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior. Oncotarget 2015;6:24230-45. [PMID: 26203771 DOI: 10.18632/oncotarget.4353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
472 Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene 2013;32:3286-95. [PMID: 22847613 DOI: 10.1038/onc.2012.334] [Cited by in Crossref: 205] [Cited by in F6Publishing: 209] [Article Influence: 20.5] [Reference Citation Analysis]
473 Zhang N, Tian L, Miao Z, Guo N. MicroRNA-197 induces epithelial–mesenchymal transition and invasion through the downregulation of HIPK2 in lung adenocarcinoma. J Genet 2018;97:47-53. [DOI: 10.1007/s12041-018-0881-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
474 Voutsadakis IA. Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities. Clin Transl Oncol. 2012;14:243-253. [PMID: 22484631 DOI: 10.1007/s12094-012-0792-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
475 Tan EJ, Olsson AK, Moustakas A. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ. Cell Adh Migr 2015;9:233-46. [PMID: 25482613 DOI: 10.4161/19336918.2014.983794] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
476 Mccaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends in Cell Biology 2011;21:727-35. [DOI: 10.1016/j.tcb.2011.06.005] [Cited by in Crossref: 158] [Cited by in F6Publishing: 152] [Article Influence: 14.4] [Reference Citation Analysis]
477 Wu SG, Chang TH, Liu YN, Shih JY. MicroRNA in Lung Cancer Metastasis. Cancers (Basel) 2019;11:E265. [PMID: 30813457 DOI: 10.3390/cancers11020265] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
478 Lee Y, Kim J, Lee J, Lee JHJ, Sahu S, Kwon H, Park S, Jang S, Lee J, Wang Z, Tam WL, Lim B, Kang N, Chang Y. Identification of Tumor Initiating Cells with a Small-Molecule Fluorescent Probe by Using Vimentin as a Biomarker. Angew Chem 2018;130:2901-4. [DOI: 10.1002/ange.201712920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
479 Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux I, Tissier A, Gras B, Pourchet J, Puisieux I, Browne GJ, Spicer DB, Lachuer J, Ansieau S, Puisieux A. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet 2012;8:e1002723. [PMID: 22654675 DOI: 10.1371/journal.pgen.1002723] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 11.5] [Reference Citation Analysis]
480 Guo W. Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance. Stem Cells Transl Med. 2014;3:942-948. [PMID: 24904174 DOI: 10.5966/sctm.2014-0020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
481 Li L, Yuan L, Luo J, Gao J, Guo J, Xie X. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. Clin Exp Med. 2013;13:109-117. [PMID: 22623155 DOI: 10.1007/s10238-012-0186-5] [Cited by in Crossref: 188] [Cited by in F6Publishing: 186] [Article Influence: 18.8] [Reference Citation Analysis]
482 Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacol Ther 2019;194:161-84. [PMID: 30268772 DOI: 10.1016/j.pharmthera.2018.09.007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 103] [Article Influence: 29.3] [Reference Citation Analysis]
483 Zhou K, Liu M, Cao Y. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network. Front Mol Biosci 2017;4:46. [PMID: 28736730 DOI: 10.3389/fmolb.2017.00046] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 12.0] [Reference Citation Analysis]
484 Tian Y, Pan Q, Shang Y, Zhu R, Ye J, Liu Y, Zhong X, Li S, He Y, Chen L, Zhao J, Chen W, Peng Z, Wang R. MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells. J Biol Chem 2014;289:36101-15. [PMID: 25371200 DOI: 10.1074/jbc.M114.598383] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
485 Datta A, Das P, Dey S, Ghuwalewala S, Ghatak D, Alam SK, Chatterjee R, Roychoudhury S. Genome-Wide Small RNA Sequencing Identifies MicroRNAs Deregulated in Non-Small Cell Lung Carcinoma Harboring Gain-of-Function Mutant p53. Genes (Basel) 2019;10:E852. [PMID: 31661871 DOI: 10.3390/genes10110852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
486 Drasin DJ, Robin TP, Ford HL. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res 2011;13:226. [PMID: 22078097 DOI: 10.1186/bcr3037] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 9.5] [Reference Citation Analysis]
487 Han C, Liu Y, Wan G, Choi HJ, Zhao L, Ivan C, He X, Sood AK, Zhang X, Lu X. The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression. Cell Rep 2014;8:1447-60. [PMID: 25176654 DOI: 10.1016/j.celrep.2014.07.058] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 7.3] [Reference Citation Analysis]
488 Sun L, Zhou X, Li Y, Chen W, Wu S, Zhang B, Yao J, Xu A. KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2. Cell Adh Migr 2020;14:182-94. [PMID: 32965165 DOI: 10.1080/19336918.2020.1826216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
489 Wu C, Guo E, Ming J, Sun W, Nie X, Sun L, Peng S, Luo M, Liu D, Zhang L, Mei Q, Long G, Hu G, Hu G. Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21. Mol Ther Oncolytics 2020;17:306-19. [PMID: 32382655 DOI: 10.1016/j.omto.2020.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
490 Miranda-Sayago JM, Fernandez-Arcas N, Reyes-Engel A, Benito C, Narbona I, Alonso A. Changes in CDKN2D , TP53, and miR125a expression: potential role in the evaluation of human amniotic fluid-derived mesenchymal stromal cell fitness. Genes Cells 2012;17:673-87. [PMID: 22747700 DOI: 10.1111/j.1365-2443.2012.01623.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
491 Futscher BW. Epigenetic changes during cell transformation. Adv Exp Med Biol 2013;754:179-94. [PMID: 22956502 DOI: 10.1007/978-1-4419-9967-2_9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
492 Song J, Zhang N, Cao L, Xiao D, Ye X, Luo E, Zhang Z. Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma. Int J Clin Oncol 2020;25:1072-8. [PMID: 32162011 DOI: 10.1007/s10147-020-01649-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
493 Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011;208:875-883. [PMID: 21518799 DOI: 10.1084/jem.20110235] [Cited by in Crossref: 369] [Cited by in F6Publishing: 358] [Article Influence: 33.5] [Reference Citation Analysis]
494 Celià-Terrassa T, Bastian C, Liu DD, Ell B, Aiello NM, Wei Y, Zamalloa J, Blanco AM, Hang X, Kunisky D, Li W, Williams ED, Rabitz H, Kang Y. Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nat Commun 2018;9:5005. [PMID: 30479345 DOI: 10.1038/s41467-018-07538-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 18.8] [Reference Citation Analysis]
495 Xu L, Tong X, Zhang S, Yin F, Li X, Wei H, Li C, Guo Y, Zhao J. ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma. Tumour Biol 2016;37:13669-77. [PMID: 27473084 DOI: 10.1007/s13277-016-5246-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]